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ABSTRACT
SUPEROXIDE DISMUTASE PROTECTS 
CARDIOMYOCYTES DURING HYPEROXIA
Mervat Elsayed Ali 
Old Dominion University, 2006 
Director: Dr. Frank J. Castora
Reactive oxygen species are implicated in tissue damage in many cardiovascular 
diseases. The current study was designed to test the hypothesis that exposure to high 
inspired oxygen concentrations (100%) damages cardiac mitochondria and that a 
biogenic response is needed for cell survival. The study was done in mice with a 
transgene (TG) for extracellular superoxide dismutase (EC-SOD) or with the EC- 
SOD gene knockout (KO). Adult EC-SOD mice and their wild type littermates and 
EC-SOD KO mice and their wild type littermates were exposed to 100% oxygen for 6 
hours and for 72 hours, and the hearts were subsequently removed under deep 
anesthesia. The mortality rate in KO mice after 72 hours (25%) was significantly 
higher than wild type littermates (10%) and TG mice (4.2%). In the EC-SOD TG 
mice, 6 hours of exposure to hyperoxia activated the transcription of nuclear genes 
important for mitochondrial biogenesis- nuclear respiratory factors (NRF-1 and NRF- 
2) and their co-regulator PGC-la -leading to expression of mitochondrial 
transcription factor A (Tfam), which regulates mitochondrial transcription and 
replication. Hyperoxia also induced activation of NRF-1 and NRF-2 in EC-SOD KO 
mice after 6 hours but down-regulated Tfam and PGC-la transcripts. But after 72 
hours, mRNA expression for NRF-2, PGC-la and Tfam increased in these mice.
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The protein expression of the pro-survival Protein Kinase B (Akt) was 
significantly increased by hyperoxia in the TG hearts after 6 hours (/?<0.05) and 
significantly decreased in KO mice (p<0.05). The protection of mitochondrial DNA 
(mtDNA) deletion was significantly higher in KO (23%) than in the TG hearts 
(3.4%). The transcription of mitochondrial 12S rRNA and nuclear COXIV increased 
significantly in TG hearts and decreased significantly in KO hearts (p<0.05). The 
pro-apoptosis markers, p-Bad and p-GSK-3(3, which are phosphorylated by Akt, 
increased significantly in TG cardiomyocytes and decreased significantly in KO 
cardiomyocytes.
In conclusion, Systemic hyperoxia consistently increases mitochondrial 
biogenesis markers in the mouse heart, most prominently in EC-SOD TG mice, and 
co-incidentally with increases in Akt, p-Bad and p-GSK-3p. This suggests that 
extracellular reactive oxygen products activate mitochondrial biogenesis and the pro­
survival pathway in TG mice. Also, hyperoxia decreased the activation of Tfam and 
PGC-la transcription after 6 hours and increased it again after 72 hours in KO mice. 
This was associated with a decrease in expression of Akt, p-Bad and p-GSK-3P and 
an increase in p38, indicating that either hyperoxia activated mitochondrial biogenesis 
and pro-survival pathways through p38 or that hyperoxia produced more oxidative 
damage to the mitochondria in the KO. In the latter case, the increase in p38 may be a 
signal for activation of apoptotic pathways.
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1CHAPTER I 
INTRODUCTION
Oxygen therapy is one of the most frequently used treatments in clinical 
medicine. It is administered to decrease and prevent tissue hypoxia in patients with acute 
and chronic cardiovascular and pulmonary diseases and also for premature infants with 
respiratory distress syndrome. Oxygen therapy is also important for many patients after 
heart surgeries such as coronary artery bypass. Ironically, oxygen at sufficiently high 
concentrations is toxic to all cells because of its propensity to accept electrons, resulting 
in incompletely reduced chemical species known as reactive oxygen species (ROS). The 
degree of oxygen toxicity is proportional to the oxygen concentration and the duration of 
exposure. Therefore, the administration of oxygen at concentrations higher than 60% at 
sea level can be toxic to the lungs, and in the newborn, to the eyes [1]. Pure oxygen 
concentrations higher than atmospheric, known as hyperbaric oxygenation, markedly 
accelerates oxygen toxicity in many organs including the lungs, the brain, and the heart.
Excessive ROS are scavenged by endogenous antioxidant defenses that protect 
the tissues from oxidative damage. The balance between ROS production and antioxidant 
capacity is very important, and its disruption contributes to the pathophysiology of 
numerous diseases. ROS are proposed to contribute to the deterioration of cardiac 
function in patients with heart diseases. It has been reported that ROS are increased in the 
failing heart, and are involved in atherosclerosis and myocardial ischemia/perfusion 
injury. Antioxidant enzymes are decreased in the decompensated heart, depressing
The journal model for this dissertation is Current Biology.
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the defenses against oxidative stress. Overexpression of antioxidant enzymes, such as the 
extracellular isoform of superoxide dismutase (EC-SOD) has been found to protect the 
lungs from oxidative damage due to hyperoxia. The effect of increased expression of the 
EC-SOD gene or its deficiency in the heart after high level oxygen concentration is 
unknown. In this dissertation, I studied the effects of hyperoxia (100% oxygen) exposure 
on heart mitochondria in mice and the role of EC-SOD in protection from high oxygen 
damage.
Hyperoxia and Production of Reactive Oxygen Species (ROS)
Molecular oxygen is an excellent terminal electron acceptor. In mitochondria, the 
high affinity of oxygen for electrons provides a large thermodynamic driving force for 
oxidative phosphorylation (OXPHOS). The transfer of four electrons leads to safe 
products (two molecules of H2O), but partial reduction generates hazardous reactive 
oxygen species (ROS). The first ROS produced in the univalent reduction pathway of O2  
to water is the superoxide anion radical (.O2"). In particular, superoxide anion, is a 
potentially destructive compound formed by the transfer of a single electron to O2 .
O2 + e —*■ .O2 (1)
In the normoxic environment only 0.1-1.0% of the electrons transferred to O2  
result in .O2" production in most cells, but the production of .O2" is markedly accentuated 
under hyperoxic conditions. Spontaneous or enzymatic [via superoxide dismutase (SOD)] 
dismutation of .O2" produces hydrogen peroxide (H2O2):
,0 2' + .0 2' + 2 H + -» H 20 2 + 0 2 (2)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Hydrogen peroxide can also be produced directly from O2 via enzymatic bivalent 
reduction. Superoxide can act as either an oxidant or a reductant, but under the 
intracellular reducing environment, it functions primarily as an oxidant. For example, 
superoxide produced by cellular reductants and autoxidation of respiratory chain electron 
carriers inactivates iron-sulfur-containing dehydratases including 6-phosphogluconate
« 9 -1-dehydratase and the citric acid cycle enzyme aconitase. Oxidation of [4Fe-4S] clusters " 
in dehydratases such as aconitase inactivates the enzymes by releasing Fe2+ from the
'y 1
cluster. Reactivation is achieved by iron-sulfur cluster reduction and Fe insertion.
9 -1-  •Inactivation-reactivation is a dynamic however Fe , can reduce H2O2 in a Fenton-type 
reaction producing hydroxyl radical (OH'):
.02" + Fe3+ -+ 0 2 + Fe2+ (3)
H2O2 + Fe2+ —» HO' + OH" +Fe3+ (4)
In addition, .O2 ' reacts with nitric oxide (NO’) at a diffusion-limited rate 
producing peroxynitrite (ONOO):
0 2" +NO' -» ONOO"
Peroxynitrite is directly toxic to molecules containing sulfhydryl groups. It also can be 
protonated to peroxynitrous acid, which spontaneously decomposes to produce an OH- 
like species and NO2 . HO' and ONOO" are among the most potent oxidants in biological 
systems, and they are capable of oxidizing DNA, proteins and lipids leading to tissue 
injury [2],
ONOO" + H+ HONOO -> .OH + N 02 (5)
Superoxide does not diffuse across biological membranes readily because of its 
negative charge. Thus, it is compartmentalized where it is produced. In the cytoplasm,
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O2" can be generated either non-enzymatically via autoxidation of small molecules such 
as thiols, hydroquinones and catecholamines, or enzymatically by various oxidases and 
dehydrogenases such as xanthine oxidase and flavoprotein dehydrogenase.
The mitochondrial electron transport chain is a major site of .O2 ' production mainly via 
autoxidation of ubisemiquinone. The microsomal electron transport system present in the 
endoplasmic reticulum is also a source of .O2". In phagocytic cells such as neutrophils and 
macrophages, the NADPH oxidase system present in the plasma membrane releases large 
amounts of .O2’ into the phagosomes and extracellular space when activated. Moreover, 
the peroxisomes are an important source of intracellular H2O2 .
Persistent exposure to high oxygen concentration (hyperoxia) increases the 
formation of more reactive oxygen species that induce damage to most of the cellular 
organelles.
ROS and Mitochondria
ROS can damage various cellular components such as proteins, lipids, and nucleic 
acids [3, 4]. ROS also mediate mtDNA damage, alterations of gene expression, and 
mitochondrial dysfunction [5]. Mitochondrial injury is evidenced by mitochondrial DNA 
(mtDNA) damage, as well as by a decline in mitochondrial RNA (mtRNA) transcription, 
protein synthesis, and general function. MtDNA is located within the matrix space of the 
mitochondria in close proximity to the electron transport chain. Due to this location, and 
its low repair capabilities, and lack of protective histone-like proteins, mtDNA is 
probably more vulnerable to oxidative damage than nuclear DNA [6, 7]. MtDNA deletion 
and mutation may prevent its replication and expression. Further, ROS may induce
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
progressive destruction of mtDNA, and this type of damage can lead to a decline in 
mtRNA transcription as well as a loss of function [8].
The mitochondrial respiratory chain Complexes I and III have been shown to be a 
major source of ROS in vitro [9]. ROS production increases in patients with 
mitochondrial cardiomyopathy [8] and recent studies have suggested a definite link 
between excessive generation of ROS and the development of myocardial remodeling 
and damage [5, 10]. Additionally, the amount of ROS generated, as determined by 
electron spin resonance spectroscopy, increases in the murine model of myocardial 
infarction [10]. Furthermore, mitochondrial electron transport has been shown to be a 
possible site for .O2- generation during heart failure.
Mitochondria Oxidation and Biogenesis
Mitochondria contain a closed, circular, double-stranded DNA of about 16.5 kb and 
16.35 kb in human and mouse, respectively. The mitochondrial genome is similar to the 
bacterial genome in that both the heavy and light strands are transcribed. The 
mitochondrial genome encodes thirteen polypeptides involved in oxidative 
phosphorylation, including seven subunits of NADH-ubiquinone oxidoreductase 
(Complex I) (ND1, ND2, ND3, ND4, ND4L, ND5, and ND6), 1 subunit (cytochrome b) 
of ubiquinol-cytochrome c oxidoreductase (Complex III), 3 subunits (COI, COII, and 
COIII) of cytochrome c oxidase (Complex IV), and 2 subunits (ATPases 6 and 8) of 
Complex V along with 22 tRNA and 2 rRNA (12S and 16S) subunits (Figure 1.1).





Figure 1.1. Illustration Map of Mouse Mitochondrial Genome. The 16.35 Kb mouse 
mitochondrial genome which includes 13 genes of the OXPHOS system 2 rRNA (12S 
and 16S) and 22 tRNA. PH and PL represent the promoters of the heavy and light 
strands. The figure also shows the site of the mtDNA deletion primers (mtfl and mtr2) 
used for the deletion analysis in the study.
Although mitochondria have their own genetic system, the protein encoding of mtDNA is 
limited to only the 13 most hydrophobic subunits of the respiratory apparatus mentioned 
above. Thus, mitochondria rely on nuclear genes to provide the majority of proteins and 
factors required for OXPHOS. Mitochondrial replication and transcription depend on 
nuclear proteins such as DNA polymerase y, RNA polymerase II and mitochondrial
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7transcription factor A (Tfam). Tfam stimulates the transcription from bidirectional 
promoters within the D-loop region, and it is also essential for mtDNA replication.
Regulation of mitochondrial biogenesis largely depends on the expression of 
nuclear respiratory factors (NRF-1 and -2). Nuclear peroxisomal proliferator-activated 
receptor gamma co-activator a (PGC-la) has been suggested as a master regulator of the 
mitochondrial biogenesis and has a major impact on the NRF system. When introduced 
into muscle cells it dramatically induces gene expression for NRF-1, NRF-2 and Tfam 
[11] (Figurel.2). Furthermore, PGC-la physically interacts with NRF-1 and co-activates 
its transcriptional activity. A dominant negative allele of NRF-1 completely blocks the 
ability of PGC-la to induce mitochondrial proliferation, indicating the importance of the 
association of the transcriptional factor/cofactor pair [12]. Furthermore, mutations that 
affect PGC-la expression lead to loss of heart mitochondria and down regulation of 
mitochondrial enzyme [13]. Interestingly, PGC-la has also been shown to be induced in 
brown fat cells upon cold stimulation, which suggests that PGC-la strongly co-activates 
several nuclear receptors (PPAR gamma, PPAR alpha, RAR and TR) that bind to 
mitochondrial uncoupling protein-l(UCP-l) enhancer [12]. In the heart PGC-la was 
found to activate the gene expression of UCP-2 and UCP-3 after LPS stimulation [14].
In contrast to nuclear-encoded genes, mitochondrial-encoded gene expression is 
primarily regulated by mtDNA copy number [15], A recent study in our laboratory [14] 
showed that lipopolysaccharide (LPS) administration to rats resulted in mtDNA deletion 
in the heart which decreased mtDNA copy number and decreased mtDNA gene 
transcription. Defective mtDNA generates more ROS by defective OXPHOS, which 
leads to more mitochondrial damage. Recovery of mitochondria after oxidation by LPS
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8was shown to involve increased mitochondrial transcriptional factor A (Tfam) and DNA 
polymerase y expression which are important for mitochondrial biogenesis. The 
transcription of other mitochondrial biogenesis markers; PGC-la and the nuclear 
respiratory factors (NRF-1 and NRF-2) is also increased after the oxidative stimulation 





Transcription activation of OXPHOS genes and mtTFA
Figure 1.2. Oxidative Stress and Activation of Mitochondrial Biogenesis Markers. 
Oxidative stress stimulates transcriptional activation of NRF-1 and NRF-2 and in the 
presence of the co-activator PGC-la they activate the transcription of OXPHOX genes 
and mitochondrial transcription factor A (mtTFA).
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9ROS and Pro-Survivai Pathways
Biogenic factors (cold, exercise, infection and oxidative stress) stimulate the
•  •  2 " hactivation of mitochondrial biogenesis. Changes in the intracellular Ca concentration 
and ATP/AMP ratio activate Ca2+/ calmodulin-dependent protein kinase (CAMK), and 
protein kinase C (PKC) has been implicated in the regulation of expression of respiratory 
genes in the skeletal muscle. Constitutive expression of CAMKIV shows an increase in 
the level of PGC-la and increased mitochondrial biogenesis [16].
It is also reported that PGC-la can be activated by a p38 MAPK-sensitive 
pathway. MAPK p38 is a stress-activated kinase that responds to extracellular stimuli 
such as UV light, heat, osmotic shock, inflammatory cytokines (TNF-alpha and IL-1) and 
growth factors [17-20]. Regulation of respiratory gene expression via p38 MAPK 
dependent pathways and induction of mitochondrial proliferation by extrinsic factors 
such as cytokines has been reported. The involvement of p38 MAPK-dependent 
pathways in oxidative stress-induced increase in mitochondrial biogenesis is not well 
established.
The pro-survival phosphatidylinositol 3 kinase (PI3K) -Akt pathway has been 
shown to activate mitochondrial biogenesis in hepatic rat mitochondria after LPS 
stimulation [21]. Akt is also stimulated by growth and survival factors [22]. There are 
three isoforms of Akt, known as Aktl (PKBa), Akt2 (PKBJ3), and Akt3 (PKBy). Aktl is 
ubiquitously expressed with high expression in heart, brain and lung [23]. All three 
isoforms of Akt share three domain structures consisting of an N-terminal pleckstrin 
homology (PH) domain, followed by a kinase domain related to protein kinases A and C
# # A .T X  •( containing Thr in Aktl) and a C terminal regulatory domain ( containing Ser in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Aktl). PH domains have high-affinity recoginition of phosphoinositide head groups. 
Activation of PI3- kinase leads to phosphorylation of membrane phosphatidylinsitol-(4, 
5)-bisphosphate [Ptdlns (4, 5) P2] generating Ptdlns (3, 4, 5) P3. Accumulated Ptdlns 
(3,4)P2 and Ptdlns (3,4,5) P3 recruit Akt containing the PH domain to the plasma 
membrane [24]. There Akt is phosphorylated at Thr308 and Ser473 [25, 26]. 
Phosphoinositide-dependent protein kinase-1(PDK1) and integrin-linked kinase (ILK) 
phosphorylate Thr 308 Ser473 respectively [27, 28].
Activation of Akt induces activation of downstream pathways important for cell 
survival and inhibition of apoptosis. Akt phosphorylates the pro-apoptotic protein Bad, a 
member of the Bcl-2 family which promotes cell survival. A second downstream pro­
survival and anti-apoptotic mechanism is through phosphorylation of the glycogen 
synthase kinase (GSK-3|3). Phosphorylation of GSK-30 leads to inactivation of the 
enzyme and reduces apoptosis [29, 30]. In addition, several studies indicate that 
activation of PI-3K/Akt suppresses caspase-3 activation and DNA fragmentation in a 
variety of cell lines [31-33].
ROS and Apoptosis
ROS function as signal transduction intermediates to induce transcription factor 
activation, gene expression, and cell growth; they also can induce apoptosis [34]. When 
the capacity of the antioxidant system is compromised, exposure of living tissue to higher 
oxidative stress will result in increased levels of defective mitochondria and mutated 
mtDNA, and thus create a cycle of increased ROS production and oxidative damage. 
When ROS increase above a threshold, mitochondrial damage irreversibly activates cell
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death. Increased ROS leads to conformational changes in the adenine nucleotide 
translocator, the voltage gated anion channel protein (porin), the peripheral 
benzodiazepine receptor, and cyclophylin that are all involved in a pore complex between 
the outer and inner mitochondrial membrane. This protein pore can open to allow 
dissipation of the mitochondrial membrane potential and pH gradient. This is referred to 
as the mitochondrial permeability transition (MPT), or opening of the mitochondrial 
transition pore [35, 36], Excess production of peroxides also oxidizes the glutathione 
pool and may also allow the formation of dithiols on the mitochondrial permeability 
transition (MPT) pore, which triggers pore opening [37], leads to the release of 
cytochrome c (cyt c), apoptosis initiation factor (AIF), and mitochondrial protective 
factors from mitochondria.
In the cyotoplasm, cytochrome c interacts with Apaf-1 and caspase 9 to activate 
caspase 3. Caspase 3 has a cleavage effect on pre-PARP, ICAD, and pre-Acinus which 
together with AIF is also released from the mitochondria. The assembly of an 
apoptosome (cytochrome c, caspase 9 and AIF-1) is directed at the nucleus leading to 
chromatin cleavage and nuclear condensation [36]. Moreover, increased ROS may induce 
the peroxidation of cardiolipin in the mitochondrial inner membrane, which triggers 
dissociation of cytochrome c from cardiolipin [38]. The release of cytochrome c can also 
be regulated by the effect of translocation of pre-apoptotic proteins (Bax and Bad) from 
the cytosol to the mitochondrial membrane in response to increases in ROS production in 
cardiomyocytes [39]. Upon translocation to the mitochondria Bax/Bad associates with the 
antiapoptotic protein Bcl-2 to form a heterodimer. Activation of caspases and nucleases 
leads to mtDNA degradations decreased mitochondrial transmembrane potential,
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uncoupling of electron transport from ATP production, increased cytosolic calcium and 
generation of more reactive oxygen species. Bad has been found to be a substrate for the 
pro-survival kinase, Akt [36]. Activation of Akt increases phosphorylation of Bad and 
prevents its association with Bcl-2 protein and prevents the initiation of apoptosis.
Akt phosphorylates another pro-apoptotic kinase, glycogen synthase kinase-3 P 
(GSK-3P). GSK-3P associates with the MPT, and phosphorylation of this enzyme on its 
serine residue number 9 results in its inactivation, and decreases opening of the 
mitochondrial MPT pores [40], Activation of Akt/GSK-3p also inhibits caspase 









Figure 1.3. Illustration Showing the Activation of Akt through PI3P and its Downstream 
Pathway. Activation of Akt through PI3P leads to activation of transcription factors in the 
nucleus and increase cell survival. In the other hand activation of anti-apoptotic proteins 
(Bad and GSK-3P) inhibit apoptosis.
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Antioxidant Systems
Cellular defense against ROS-mediated injury includes both enzymatic and non- 
enzymatic antioxidant systems. While non-enzymatic antioxidants such as reduced 
glutathione (GSH), a-tocopherol (vitamin E), and ascorbic acid (vitamin C) serve 
important role in cellular antioxidant defense, the enzymatic antioxidant system plays the 
major roles in the cellular defense against oxygen toxicity. The superoxide dismutases, 
catalase, and the glutathione peroxidases constitute the major enzymatic antioxidant 
systems.
Superoxide Dismutases (SOD)
Superoxide dismutases are the most important class of antioxidant enzymes; they 
are metalloenzymes that catalyze the dismutation of two superoxide radicals (.O2 ) into 
hydrogen peroxide (H2 O2) and oxygen (O2) [41]. H2O2 can be further metabolized to 
water by catalase or other peroxidases. In 1969, the first antioxidant enzyme, Cu,Zn 
superoxide dismutase (SOD), was identified in the erythrocyte by McCord and Fridovich, 
who found it to catalyze the rapid dismutation of superoxide radical to hydrogen peroxide 
and oxygen (dissociation constant (Kj) ~ 3 X 109 M'1 s'1) [42]. Three isoforms of SOD 
have now been identified in mammals. The Cu,Zn isoform (SOD1) is the major 
intracellular SOD, and is found primarly in the cytosol, but may also appear in the 
nucleus, in lysosomes and in the space between the inner and outer mitochondrial 
membranes. Manganese SOD (SOD2), found in the mitochondria, has Mn in the active 
site. MnSOD plays an important role in protecting mitochondria from superoxide anions 
produced as a byproduct of electron transport required for oxidative phosphorylation.
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Extracellular superoxide dismutase (SOD3) is present mainly in the extracellular matrix. 
EC-SOD is considered the principal antioxidant enzyme in the extracellular spaces which 
protects the extracellular space from oxidant stress. The Cu and Zn containing SOD, 
CuZnSOD and EC-SOD, constitutes approximately 85-90% of the total SOD activity in 
the mouse tissues, while MnSOD constitutes approximately 10-15% of total SOD 
activity.
Molecular and Biological Characters of EC-SOD
The existence of extracellular SOD was suggested in 1980 by Stephan Marklund 
[43]. Examination of human serum and cerebrospinal fluid by gel chromatography 
revealed that extracellular fluid contains SOD activity that was immunologically distinct 
from the intracellular CuZn SOD [44].
The high molecular weight SOD was subsequently purified from human lungs 
where it is highly expressed and named extracellular superoxide dismutase (EC-SOD) 
[45]. EC-SOD is a hydrophobic glycoprotein with molecular weight of approximately 
135 kd with minor species-specific differences. In most species, EC-SOD is a tetramer of 
identical 30 kd subunits, although it is occasionally found as a dimer. The tetramer is 
comprised of two dimers linked through disulfide bridges [46, 47]. The enzyme contains 
one copper and one zinc ion coordinated to the side chain of a histidine residue in the 
active site that catalyzes dismutation of the superoxide anion with a rate constant of 109 
M'1 s'1. The copper ions are catalytically active in the dismutation reaction. The Zn does 
not function in the catalytic cycle, but stabilizes the enzyme during the reaction. As a 
copper-containing enzyme, the activity of EC-SOD is regulated by copper availability.
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Free intracellular copper is extremely limited [48], and soluble carrier proteins or “copper 
chaperones” are used for copper trafficking to specific copper-containing proteins. The 
copper chaperone that delivers copper to EC-SOD and regulates its activity is called 
antioxidant-1 protein (Atoxl) [49]. The copper ions appear to function in the dismutation 
reaction by undergoing alternate oxidation and reduction as summarized in the following 
equations:
SOD-Cu2+ .02 -*• Enzyme-Cu+ + 0 2 (5)
SOD-Cu+ + ,02' + 2H+ —+ Enzyme- Cu2+ + H20 2 (6)
The net reaction of the above 2 reactions is:
.02- + .02 + 2H+ -► H20 2 + 0 2 (7)
Analysis of cDNA isolated from a human placental cDNA library revealed that 
EC-SOD contains 240 amino acids including an 18 amino acid signal peptide for 
secretion [50]. The remaining 222 amino acids make up the mature protein. The first 95 
amino acids showed no sequence homology with other proteins, but a possible N- 
glycosylation site was identified at Asn-89. 50% sequence homology with other 
eukaryotic CuZn SOD’s is present in residues 96-193 of EC-SOD. Amino acids 194-222 
are hydrophilic and contain nine positively charged amino acids, which were believed to 
contribute to EC-SOD’s affinity to heparin and heparin sulfate (Figurel.4).
The mature human EC-SOD contains six cysteine residues [50], and occurs 
naturally in two different forms with evident disulfide bridges [51]. One form is active 
(aEC-SOD) and has a free cysteine residue in position 195. The intrasubunit disulfide 
bridge formed by Cysl07 and Cysl89 is necessary for the SOD activity [51]. The other 
form has a free cysteine residue at position 45 and is inactive (iEC-SOD). EC-SOD is
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Figure 1.4. Schematic Showing the Structure of the EC-SOD Dimer. The N-terminal 
amino acid residues and the position of the single iV-linked glycan at Asn89 are indicated. 
The putative intrachain disulfide bridge between Cys107 and Cys189 or possible Cys190 is 
shown based on the homology to Cu/Zn-SOD. The C-terminal amino acid residues 
include the heparin binding domain.
unusually resistant to high temperatures, extreme pH, and high urea concentrations, 
although it can be inhibited by a variety of agents including azide and cyanide and 
inactivated by diethyldithiocarbamate and hydrogen peroxide.
The C-terminal region is highly rich in basic amino acid residues [50]. This 
polybasic region is involved in the binding to heparin/heparan sulfate [52] and type I 
collagen [53], and is referred to as the extracellular matrix (ECM)-binding region [53]. 
The heparin-binding domains of two EC-SOD subunits are linked by a disulfide bond to 
form a cluster of 12 positively charged amino acid residues (Figure 1.2) [47]. These 
residues provide the basis for the electrostatic interactions with heparin sulfate which 
anchors EC-SOD to specific regions of the extracellular matrix and on the cell surface.
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The ECM region is removed proteolytically just before secretion. This produces both 
intact and cleaved subunits of EC-SOD. Hence, the enzyme is heterogeneous in its 
affinity for heparin three subtypes of EC-SOD exist; type A has no affinity, type B, with 
intermediate affinity, and type C, with high affinity for heparin [54]. The heparin-binding 
domain has been proposed to act as a nuclear localization signal in culture cells (3T3-L1) 
[55], suggesting that the role of EC-SOD is to protect the genome DNA from damage by 
reactive oxygen species and /or the transcriptional regulation of redox-sensitive gene 
expression [56].
A natural mutation located in the center of the carboxyl-terminal cluster of 
positively charged amino acid residues, which defines the heparin-binding domain, has 
been described for human EC-SOD where ArgGly (R213G). The effect of this 
polymorphism, which is found in 4% of Swedish, 3% of Australian and 6% of Japanese 
people, increases the concentration of EC-SOD in the plasma of homozygous individuals 
10 to 30-fold [57, 58]. This increase in EC-SOD blood concentration, which reflects 
decreased tissue antioxidant levels, has now been shown to increase the risk of ischemic 
heart disease [58].
The genomic structure and chromosomal localization of the EC-SOD gene has 
been mapped in humans to chromosome 4q21, and in mouse to chromosome 5. The 
human EC-SOD gene consists of three exons and two introns, while the mouse has two 
exons separated by a 4 kb intron. The entire human EC-SOD coding region (720-bp) is 
located within exon 3 [59]. The promoter regions of human and mouse EC-SOD 
apparently lack classical TATA or CCAAT boxes. In humans, the promoter region of the 
gene contains various regulatory elements including two potential antioxidant response
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elements (ARE), AP-1 binding sites, xenobiotic response elements, NF-B motifs, and 
C/EBPbeta-binding sites [50, 60, 61].
Regulation of EC-SOD Transcription and Protein Expression
The expression of EC-SOD mRNA and protein, unlike, SOD1 and SOD2, is cell- 
and tissue-specific and is prominent in heart, lung, blood vessels, placenta, and kidney. 
High levels of EC-SOD mRNA and protein are present in alveolar type II cells, proximal 
renal tubular cells, lung macrophages, vascular smooth muscle cells, some fibroblast 
lines, glial cells, and endothelial cells. Despite detailed promoter analysis that reveals 
multiple potential regulatory sequences, as described above, mechanisms regulating this 
cell-specific enzyme expression are not yet known.
In vitro studies in skin fibroblasts indicate that heparin and heparan sulfate induce 
both EC-SOD mRNA and protein expression. In vascular smooth muscle cells (VSMC) 
and lung alveolar type 2 cells, inflammatory cytokines such as TNF-a and IFN-y are a 
potent combination for induction of EC-SOD mRNA and protein expression. Angiotensin 
II strongly induces EC-SOD activity in mouse aorta and in cultured human smooth 
muscle cells [62] through transcriptional activation and stabilization of the mRNA. This 
effect is mainly due to activation of ERK (p42/p44 MAP kinases). Exercise training, 
which increases production of nitric oxide in mouse vessel endothelial cells, in turn up- 
regulates expression of EC-SOD in adjacent smooth muscle cells [63]. In this study, 
nitric oxide exerted its effect through the MAP kinase p38 pathway. This is an example 
of the important relationship between EC-SOD and endothelial nitric oxide synthesis. 
While certain stimuli induce EC-SOD expression, a variety of growth factors repress EC-
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SOD mRNA expression. These include TGF-(5 in human fibroblasts [64] and PDGF and 
FGF in vascular smooth muscle cells [62].
In a recent study, plasma EC-SOD levels were measured in type 2 diabetic 
patients and found to be significantly and inversely related to insulin resistance. 
Interestingly, the authors concurrently reported that in cultured fibroblasts, the 
C/EBPbeta enhancer, prolactin, which regulates genes associated with insulin resistance, 
significantly induced EC-SOD transcription and protein expression [65]. Understanding 
the complex regulation of EC-SOD will facilitate further studies to define the role of EC- 
SOD in different disease states.
Biological Role of EC-SOD
EC-SOD is the only known antioxidant enzyme that scavenges superoxide 
specifically in the extracellular compartment. Superoxide has only a few direct targets, 
but it does maintain iron in the reduced state, which is then available to participate in 
Fenton chemistry to produce hydroxyl radical, a highly reactive and toxic ROS. In 
addition, superoxide reacts rapidly with nitric oxide (Kd ~ 6.7 X 109 M'1 s'1) to deplete 
nitric oxide bioactivity and form a strong oxidant, peroxynitrite. EC-SOD limits these 
toxic extracellular reactions. Numerous studies utilized EC-SOD transgenic and knock­
out mouse models to show its role in protecting or amplifying tissue injury.
EC-SOD and Diseases
Disruption of EC-SOD localization or activity may contribute to increased ROS 
and impaired nitric oxide-mediated vasodilation in cardiovascular diseases [66]. EC-SOD
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protects against oxidation of LDL, a major contributor to atherosclerosis, and EC-SOD 
activity is reduced in patients with coronary artery disease. In diabetes, glycation of EC- 
SOD is associated with a decrease in heparin affinity and impaired vascular function [64], 
Furthermore, in cardiac ischemia/reperfusion, over-expression of EC-SOD in transgenic 
mice or treatment with recombinant EC-SOD preserves cardiac function and decreases 
infarct size. A protective effect for EC-SOD has also been reported in 
ischemia/reperfusion injury in the brain and kidney. As EC-SOD promotes nitric oxide- 
mediated vasodilation, [67] so it is suggested that antioxidant treatment improves 
coronary and peripheral endothelial function in patients with coronary artery disease or 
coronary risk factors [68]. Previous studies showed that overexpression of EC-SOD in 
new bom mice protected lung development in hyperoxia-exposed newborn mice [69]. 
Also overexpression of EC-SOD in the airways of the transgenic mice had been shown to 
reduce inflammation and attenuates lung toxicity [70].
The effect of hyperoxia exposure on the heart of the transgenic EC-SOD or the 
EC-SOD knockout mice has not been studied before. In this study, I investigated the 
effect of exposure to 100% oxygen at sea level (hyperoxia) on cardiac mitochondria of 
the transgenic and knockout EC-SOD mice and also the effect of hyperoxia on the 
activation of mitochondrial biogenesis and cell survival in these mice.
General Hypothesis and Research Objectives
General hypothesis: Extracellular superoxide dismutase (EC-SOD) plays an 
important role in scavenging superoxide radicals in the extracellular milieu, and it also 
decreases the oxidative damage to the intracellular compartment especially to
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macromolecules such as DNA and RNA. Based on these actions of EC-SOD, I 
hypothesized that EC-SOD functions to protect cardiac mitochondria from oxidative 
damage after exposure to hyperoxia (100% oxygen), and improves cell survival through 
activation of mitochondrial biogenesis. This hypothesis was tested in mice in which 
levels of EC-SOD were genetically altered, which allowed me to investigate the research 
objectives.
Specific Aims:
1- Study the effect of overexpression and lack of expression of EC-SOD on activation 
of cardiac mitochondrial biogenesis after hyperoxia exposure.
2- Study the effect of hyperoxia in inducing damage to mtDNA, and mitochondrial 
RNA transcription in genetic altered EC-SOD mice.
3- Test the hypothesis that the overexpression of EC-SOD will protect 
cardiomyocytes from apoptosis which leads to cellular death.
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CHAPTER II 
MATERIAL AND METHODS 
Animal Protocol
The protocol was approved by The Duke University Animal Care and Use Committee. 
The study was carried out in two separate groups - the EC-SOD transgenic (TG) group 
and their wild type (C57/BL6-C3) control and EC-SOD knockout (KO) and their wild 
type (C57/BL6-J) control group. Both male and female mice were equally represented in 
each group and they were between the ages of 9-12 months old.
Transgenic mice (TG) used in this study were generated by Oury et al., (1992) [71] using 
an expression vector comprised of the human p-actin promoter coupled to a full-length 
cDNA encoding for human EC-SOD. This linearized transgene construct was 
microinjected into the pronuclei of fertilized single-cell mouse embryos, which were re­
implanted into the oviduct of adult female mouse. Offspring were screened for the 
presence of the transgene by Southern blot and/or polymerase chain reaction analysis of 
DNA. A founder mouse was then bred with B16-C3 (FI) mice.
Knockout mice (KO) were generated by Carlsson et al., (1995) [60]. The mouse EC-SOD 
coding region (exon 2) was replaced with the gene encoding the neomycin-resistance 
gene by homologous recombination in embryonic stem (ES) cells. The blastocysts were 
isolated from C57/BL6-J mice on day 3.5 of pregnancy, and then ES cells were injected 
into each blastocoele cavity. The blastocysts were introduced into the uterine horns of
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pesudopregnant (C57/BL6-J X CBA) FI mice. Offspring were screened for the presence 
of the EC-SOD null by Southern blot. The null mice were bred with C57BL/6 mice and 






B S  EB H
 I t e s r - - - 1
HSW-TWMee
H EB H
- J L g y - L
Mt*3
-/+ +/+ -/+ -/» +/+ -/- *»/» -/+ -/+
Figure 2.1. Illustration Map of of EC-SOD Knockout Gene. A, Restriction map of the 
native mouse EC-SOD gene and the disruption of the EC-SOD exon with the neomycin 
gene. B, Southern Blot analysis, the wild type gene was recognized as a 6.5 kbp 
fragment, whereas the EC-SOD knockout gene was recognized as 3.8 kbp fragment [57].
Exposure to Hyperoxia
Mice were randomly assigned and placed in small-animal chambers with an airtight 
oxygen flow rate of 10 L/min. The concentration of oxygen in the chambers was 
monitored continuously with a Servomex O2 analyzer (model 572, Sybron, Norwood, 
Massachusetts, USA) and maintained at > 99%, except for 10 min/day when the cages 
were opened to room air during periods of cleaning and general maintenance. The CO2
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concentration was held below 0.1%, the temperature between 25°C and 26°C, and the 
humidity was < 40%. The mice were provided ad libitum access to food and water and 
frequently observed for signs of discomfort or O2 toxicity. We exposed two groups of 
mice for each experiment, one group for 6 hours and the second group for 72 hours. We 
chose these two early (6 hours) and late (72 hours) time periods because at 6 hours 
significant changes in the expression of mitochondrial biogenesis markers were observed 
and 72 hours was the maximum time that oxidative damages after exposure to hyperoxia 
were observed (personal communication with Dr. Piantadosi). Control mice were kept in 
identical chambers and exposed only to room air.
Harvest the Mouse Heart
After 6 hours and 72 hours exposure the mice were euthanized using Halothane, the 
thoracic cage was opened and the hearts were harvested and snap frozen in liquid 
nitrogen and stored in -80°C until use. Mice were taken out of the hyperoxia chamber 
individually at the time of sacrificing because acute drops in oxygen concentration (100% 
to normal air 21%) caused death in mice that had been exposed to O2 for 72 hours.
Total RNA Isolation
All RNA work was done in a specific area designated for RNA extraction and analysis. 
All equipment and glassware were cleaned using RNAase ZAP. TRIZOL reagent (Life 
Technologies) was used according to the manufacturer’s instructions:
1-The mouse heart was weighed. For each 100 mg of heart tissue 1ml of TRIZOL 
Reagent was added on ice.
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2- The heart was homogenized using a Polytron (Power Gen 125, Fisher Scientific). The 
Polytron was washed with DEPC water (RNAase free water) before each sample. The 
homogenization was carried out for 10 seconds twice with an interval of 15 seconds. 
After homogenization, the sample was left for 5 minutes at room temperature for 
complete dissociation of nucleoprotein complexes.
3- Two hundred microliters of chloroform per 1 ml of TRIZOL Reagent were added and 
the sample was shaken vigorously by hand for 15 seconds followed by incubation at 
room temperature for 2-3 minutes.
4-The sample was centrifuged in a cold microcentrifuge at 4°C at 12,000 x g for 15 
minutes to separate the homogenate into an aqueous phase and lower red phenol 
choloroform phase (RNA is in the aqueous phase). Three hundred microliters of the 
aqueous phase was transferred into a clean 1.5 microcentrifuge tube and 500 pi of 
isopropyl alcohol was added to each sample. The sample was gently mixed and left at 
room temperature for 10-15 minutes to precipitate the RNA.
5-The sample was centrifuged at 12,000 x g at 4°C for 10 minutes. The RNA pellet was 
washed with 75% ethanol in DEPC water (1ml ethanol: 1 ml of TRIZOL).
Next, the sample was centrifuged at 7500 x g for 5 minutes at 4°C. The RNA pellet was 
left to air dry for 5 minutes and resuspended in 50 pi of DEPC water and incubated at 
55°C for 5 minutes to completely dissolve the RNA pellet.
6-The RNA concentration was measured by diluting 3 pi of sample in 147pi of TE buffer 
(Tris- EDTA). The RNA concentration was assayed by spectrophotometer at wavelength 
260 nm. We also assayed the absorbance at 280 nm (to check for protein contamination
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in the sample). The 260/280 ratio was 1.8-2 in all samples. The RNA concentration was 
calculated according to the equation:
RNA concentration = OD value at 260 x 50 (the dilution factor) x 40.
RNA Gel Electrophoresis
The extracted RNA was separated on 1 % agarose gels in IX TEA Buffer in sterile water 
to check the yield of the extraction and the integrity of the RNA. Three microliters of 
RNA were diluted with 4 pi of DEPC water and 3 pi of RNA loading buffer (Sigma) and 
loaded into the gel. The separation was performed at 70 volts using a Bio RAD power 
supply (Model 200/2.0).
Mitochondrial and Nuclear mRNA Expression
One microliter of RNA from each sample was reverse transcribed in a total volume of 25 
pi using Moloney murine leukemia virus reverse transcriptase (180 units, Promega) in a 
reaction buffer containing dNTPs (2 pi), 0.5 pi Oligo dT primers and random primers in 
a ratio 3:2 , DTT (2 pi) and ribonuclease inhibitor RNasin (1 pi) (Promega). First, 1 pg of 
RNA was brought up to 13.5 pi with sterile water and incubated in a heat block at 70°C 
for 5 minutes to remove the secondary structures. Then, the samples were returned to ice 
and 11.5 pi of RT mix was added and incubated in the oven at 42°C for 90 minutes. 1 pi 
of the cDNA was amplified using PCR with the different oligonucleotide primers as in 
(Table 2.1) to measure the expression level of mRNA of PGC-la, NRF-1, NRF-2, Tfam, 
12S rRNA, COX IV, MnSOD and GAPDH. The number of PCR cycles was optimized 
during the exponential phase of the PCR by titration of visible products on Gel Star-
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stained agarose gels. Quantification of amplified mRNA signal was done by densitometry 
normalized to GAPDH mRNA signal density for each sample using image analysis 
software (Bio-Rad).
Protein Expression
Preparation of the sample. Protein expression was assayed by Western immunoblot 
analysis. Frozen mouse heart tissue was homogenized in Tris phosphate buffer at pH 7.5 
with antiproteases in a ratio 1:10 respectively. The phosphate buffer contains 20 mM 
Tris, 150 mM NaCl, 1 mM EDTA, ImM EGTA, 1% Triton X-100, 2.5 mM sodium 
pyrophosphate, ImM B-glyerophosphate, 1 mM Na3V0 4 , lpg/ml Leupeptin and ImM 
PMSF. The sample was homogenized using Polytron on ice 3 times for 15 seconds each 
and cooled on ice for 30 seconds between homogenizations. Next, the sample was 
centrifuged in a cold centrifuge (RC-5 Superspeed refrigerated centrifuge, Sorvall) at 4°C 
at 10,000 x g for 10 minutes to pellet down the nuclei and cellular debris. The supernatant 
was decanted to a new tube. An aliquot was saved for protein assay and the rest of the 
sample was mixed directly with an equal volume of (2x) SDS (Laemmli buffer) 125 mM 
Tris-HCl, 4 % Sodium Dodcyl Sulfate (SDS), 20% Glycerol, 100 mM Dithiothreitol 
(DDT) and 0.02% Bromophenol blue. The sample was then boiled on a heating block at 
95°C for 5 minutes to denature the protein.
Protein Assay
Protein concentration by the Bicinchoninic Acid Method. Reagent A which contains 
1% Bicinchoninic Acid and Reagent B which contains 4% Cupper Sulfate (CUSO4 5 H2O)
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Table 2.1. Primer Sequences Used to Amplify Mitochondrial and Nuclear mRNA
Gene Name Sequence
MnSOD Sense: 5’ GGCCAAGGGAGATGTTACAA 3’
Antisense: 5’ GCTTGAT AGCCT CC AGC A AC 3’
Tfam Sense: 5' GGAAGAGCAGATGGCTGAAG 3’
Antisense: 5’ CCCAATGACAACTCCGTCTT 3’
COX IV Sense: 5’ GT C AC ACGAGAC AGAT GA 3’
Antisense: 5’ CATCGAAGGGAGTTTACA 3’
PGCla Sense 5’ AGCCAGCAGTTTGGTTCTTG 3’
Antisense: 5’ CC ACTTT GCCTT CC AC AA AT 3’
NRF-1 Sense: 5’ CCACGTTGGATGAGTACACG 3’
Antisense: 5’ CT GAGCCT GGGT C ATTTT GT 3’
NRF-2 Sense: 5’ CCGCTACACCGACTACGATT 3’
Antisense: 5’ ACCTTCATCACCAACCCAAG 3’
12S rRNA Sense: 5’ GAATTACGGCTCCTGCTCA 3’
Antisense: 5’ GGAGGCAAGCATAAGACTG 3’
GAPDH Sense: 5’ TT C ACC ACC AT GGAGAAGGC 3’
Antisense: 5’ GGCATGGACTGTGGTCATGA 3’
All the primers are synthesized using mouse mitochondrial genome from the gene bank 
(accession # NC006914) by Invitrogen.
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were mixed together to make a working solution in a ratio 49:1. Bovine Serum Albumin 
was used to make standard curve from a stock concentration of 1 mg/ml. Serial dilution 
ofthe standard was made; 5 pg, 20pg, 40pg, 80 pg, and 160 fig. One ml of the working 
solution was added to each tube of the standard and the samples and 5 pi of the protein 
homogenate was added to each sample tube run in triplicate. 160 pi of distilled water was 
added to each sample tube to make the final volume equal to the volume of the standard. 
Both the sample and the standard tubes were incubated in a water bath at 60°C for 30 
minutes. Then, 3 ml of distilled water was added to each tube to dilute the concentrated 
purple color. Next, the OD was measured at wavelength 562 nm (Spectrophotometer, 
Hitachi, U-2000). A standard curve was plotted using computer software and actual 
protein values of the samples were obtained.
Gel Electrophoresis for the Protein Sample
The samples were separated on 4-20% gradient polyacrylamide, 15 wells minicassette 
gels (Invitrogen). 20 pg of the protein sample was loaded on the gel from each diluted 
SDS sample. Color protein Marker (Sigma) was used to identify the bands of interest in 
each experiment. Electrophoresis Tris glycin (10 mM) running buffer was used and the 
samples were separated at 125 Volts and a constant current of 36 Amps for 90 minutes 
using a power supply (Bio-Rad).
Transfer Protein Sample to Immobilon Membrane
The protein bands that were separated on the polyacrylamide gels were electro­
transferred to an Immobilon membrane with a pore size of 0.045mm (Millpore
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Corporation). The Immobilon membrane was pre-washed in methanol for 2 minutes and 
then in transfer buffer for 10 minutes before the transfer. The transfer was done at 
constant current (500 Amps) for one-hour using transfer buffer (25 mM Tris base, 192 
mM glycine, 20% methanol in distilled water at pH 8.3). After the transfer, the membrane 
was blocked in 5 % non-fat dry milk for 30 minutes followed by a wash with Tris 
Buffered Saline with Tween 20 (TBS-Tween) (Sigma) three times for 10 minutes each.
Immunoblotting the Immobilon Membrane
1-The membranes were incubated with different primary antibodies (Akt, pAkt, p38, p- 
p38, p-Bad, pGSK-3B, CAMKIV, alpha-actinin and tubulin antibodies) (Table 2.2) in 5% 
non-fat dry milk overnight at 4°C on the shaker.
2- The membrane was washed with TBS-Tween buffer (Sigma) for 10 minutes 3 times 
and incubated with HRP-labeled secondary antibodies with dilution 1: 2000 in 5 % milk 
for one hour at room temperature.
3-The membrane was washed 3X with TBS-Tween to remove unbound secondary 
antibody.
4-Enhanced Chemilluminescence Detection Reagents (Amersham) were used to detect 
the protein signal. The HRP/hydrogen peroxide present in the secondary antibody 
catalyzes the oxidation of luminol in alkaline conditions. After oxidation, the luminol is 
in an excited state that then decays to a ground state by emitting light. The light reaches a 
peak after 5-20 minutes and decays slowly with a half life of approximately 60 minutes. 
Maximum light emission is detected at 428 nm.
5-The membrane was exposed to x-ray film and developed in a Philips x-ray developer.
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Table 2.2. Primary Antibodies used to detect the Level of Protein Expression in the 
Mouse Heart in the Study
Antibodies Type of Antibody Dilution Size of the band Cataloge# Source
P-P38 Polyclonal 1:800 38 KD sc-17852 Santa Cruz
P38 Polyclonal 1:1000 38 KD sc-535 Santa Cruz
pAkt Polyclonal 1:1000 60 KD sc-16646 Santa Cruz
Akt Polyclonal 1:1000 60 KD sc-8312 Santa Cruz
p-Bad Polyclonal 1:1000 45 KD 5284 Cell Signaling
P-GSK-3P Polyclonal 1:1000 30 KD sc-9166 Santa Cruz
a-Actinin Monoclonal 1:1000 100 KD sc-17829 Santa Cruz
CAMK-IV Monoclonal 1:800 59 KD sc-1545 Santa Cruz
P-Tubulin Monoclonal 1:1000 45 KD T-4026 Sigma
Phosphorylated (p) and total primary antibodies were used to detect the expression level 
of the activated (phosphorylated) protein and the level of the total protein.
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Mitochondrial DNA Deletion
MtDNA was analyzed for a deletion between direct repeats (direct repeat 16 
corresponding to bp 1095 -  4905 of mouse mtDNA) (Figure 2.2) by polymerase chain 
reaction (PCR) using mouse mtDNA deletion primers as shown below in Table 2.3 [72] 
and Takara Ex Taq Kit ( Takara BIO INC.). The total DNA was extracted by Gen Elute 
Mammalian Genomic DNA kit (Sigma), as follows:
1-Frozen heart tissue from mice exposed to hyperoxia and non-exposed (air) mice were 
allowed to thaw on ice and then minced into small pieces to enable more efficient lysis.
2-180 pi of STL Buffer was added to about 50 mg of heart tissue. Twenty microliter of 
proteinase K (5%) was added and the samples were mixed by vortexing and incubated at 
55°C for 4 hours until the tissues were completely digested.
3- After complete digestion 200 pi of SL Buffer was added to the samples and vortexed 
thoroughly for 15 seconds followed by incubation at 70°C for 10 minutes.
4- Two hundred micoliters of ethanol (95-100%) was added to the sample, and mixed 
thoroughly by vortexing for 5-10 seconds. The contents of the tube were transferred into 
a pre-assembled binding column.
5-The sample was centrifuged at 6500 x g for 1 minute. The collection tube was 
discarded and 500 pi of lx SW Buffer was added to the binding column to wash and 
centrifuged at 6500 x g for 1 minute. Afterwards, the collection was discarded. The wash 
step was repeated with centrifugation for 3 minutes at maximum speed (12,000-16,000 x 
g) to dry the binding column and to be sure it was free of ethanol.
6- Two hundred microliters of SE Buffer was pipetted into the center of the binding 
column and incubated for 5 minutes and then centrifuged for 1 minute at 6500 x g to
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elute the DNA. The eluted DNA was stored at 4°C and used for detection of mtDNA 
deletion in the WT, TG, and KO mouse hearts.
7- The DNA sample was amplified using the SQPCR and the mtDNA deletion primers. 
The PCR conditions were: first cycle 96 °C for 2 minutes, second cycle 96 °C for 50 
seconds, annealing at 50 °C for 40 seconds and extension at 72 °C for 1 minute for 40 
cycles with final extention at 72 °C for 6 minutes. The number of PCR cycles was 
optimized during the exponential phase of the PCR by titration of visible products on Gel 
Star-stained agarose gels.





S’ agtcgtaacaaggtaagcat3’ S’ atttctactccttttageat3’
Figure 2.2. Illustration of mtDNA Deletion Primers. The expected mtDNA deletion 
occurs between two 16-bp direct repeat sequences 5' act aac cct age cct a 3' (1095-1110) 
and 5' tac cct aac cct acc g 3' (4890-4905). The 16-bp direct repeats are represented by 
boxes labeled (a and b). Primers 1 and 2 amplify the 859-bp fragment in the presence of 
the 3810-bp deletion in the mtDNA. The genes in this region include ND1, ND2, COX1, 
16S rRNA and tRNA for six amino acids.
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Table 2.3. Mouse Mitochondrial DNA Deletion Primers Sequences
Primer Nucleotide Position Sequence
mtfl 982-1001 bp AGTCGTAAGGTAAGCAT
mtr2 5632-5651 bp ATTTCTACTCCTTTTAGCAT
Mitochondrial DNA forward primer (mtfl) and reverse primer (mtrl) designed to detect 
deletion in mouse heart mitochondrial DNA.
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EC-SOD Activity Assay
EC-SOD activity was measured by inhibition of cytochrome c reduction as described by 
Crapo (1978) [73]. Four heart tissues from control and transgenic mice in air and after 72 
hours exposure to hyperoxia (100% oxygen) were weighed and homogenized in 10 
volumes of ice-cold 50 mM potassium phosphate buffer (pH 7.4) with 0.3 M KBr, and a 
set of antiproteolytic agents (0.5 mM phenyl methylsulfonyl fluoride, 3 mM 
diethylentriaminepentaacetic acid, 90 mg of aprotinin per liter, 10 mg of pepstatin per 
liter, 10 mg of chymostatin per liter, and 10 mg of leupeptin per liter). The homogenate 
was then sonicated, and separation of EC-SOD from CuZn-SOD and Mn-SOD was 
accomplished by passage over a concanavalin A-Sepharose column as described 
previously [74]. The EC-SOD activity was measured by inhibition of cytochrome c 
reduction at pH 10. One unit of SOD activity is defined as the enzyme activity needed to 
inhibit a 50% reduction in cytochrome c.
Statistical Analysis
Grouped data were expressed as mean ± SD. Group sizes were n= 4 or 5 for all studies. 
Statistics were performed using two-way ANOVA (analysis of variance) followed by 
Tukey’s post hoc comparison using Sigma Plot computer software. A p  value of 0.05 or 
less was accepted as significant.




Because the EC-SOD TG was developed in a strain (C57/B16-C3) different than the one 
used for EC-SOD KO (C57/B16-J), we used two different wildtype strains that match 
with the respective mouse strain as reference controls. The results from the transgenic 
and the knockout mice are separated in the following two parts. The difference of 
mitochondrial and nuclear gene expression between each animal group and its control at 
the base line (air) was summarized in Table 3.1. Also, the effect of hyperoxia for 6 hours 
and 72 hours on the expression of mitochondrial and nuclear genes in the EC-TG and KO 
mice is summarized in (Table 3.2 and Table 3.3).
Part I: Effect of Hyperoxia in EC-SOD Overexpressing Mice (TG)
Hyperoxia and Mortality
On exposure to 100% oxygen: after 24 hours the mice started to huddle together and 
there were no signs of respiratory distress but prolonged exposure for 72 hours was lethal 
to some mice. Hyperoxia was lethal to 12.5% of the exposed WT mice (3/24), while the 
mortality rate was lower in the TG mice 4.2% of the exposed mice (1/24), Table 3.4.
Effect o f Hyperoxia on Cardiac mtDNA
Hyperoxia increases reactive oxygen species (ROS), which can be deleterious to 
macromolecules such as DNA and RNA. Because mtDNA is sensitive to damage by 
ROS, the integrity of mtDNA was assessed by semiquantitatve PCR to detect deletion of 
a specific GC-rich region vulnerable to oxidation [72]. The PCR product of the intact
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wild type (WT) mtDNA is 4669 bp, while the size of the deletion between direct repeats 
is 3810-bp, producing a PCR product of 859 bp. This deletion was detectable in both WT 
and EC-SOD transgenic (TG) mice after oxygen exposure for 72 hours but it was absent 
in their littermate air-control mice (Figure 3.1). The amount of deletion was higher in the 
WT (4.8%) group than the TG mice (3.4%) but the difference was not statistically 
significant.
Hyperoxia and Mitochondrial RNA Transcription
To further evaluate the damage to mtDNA after hyperoxia, the efficiency of 
mitochondrial gene transcription was measured using RT-PCR. The level of expression 
of 12S rRNA was not different between WT and TG mice at room air (Figure 3.2). 
However after 72 hours there was significant decrease in the expression in the WT than 
in the TG mice (p<0.05). However, 72 hours of hyperoxia induced a significant decrease 
in 12S rRNA expression in the WT compared to their littermate air-control mice 
(p<0.05).
Hyperoxia and Nuclear Gene Transcription
To investigate the possibility that hyperoxia induced oxidative damage to the nuclear 
genome essential for mitochondrial function, the expression level of COX IV mRNA was 
measured. COX IV is a mitochondrial ETC (OXPHOX) subunit protein of Complex IV 
encoded by the nuclear genome. At baseline the cardiac transcripts of COX IV were 
significantly higher in WT than TG control mice (p<0.05). After hyperoxia the WT
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COX IV mRNA level did not change significantly but COX IV mRNA level in TG heart 
increased significantly (about 40%, /?<0.05) (Figure 3.3). This result indicates that 
oxidative stress in EC-SOD TG mice might up-regulate transcription of nuclear genes 
essential for mitochondrial respiration.
Effect o f Hyperoxia on Cardiac SOD Activity
Total SOD activity was significantly higher in heart homogenate in TG compared to WT 
mice (Figure 3.4A) and was mainly due to increases in the EC-SOD isoenzyme, which 
was about 2-fold higher (Figure 3.4B). Exposure to hyperoxia decreased WT EC-SOD 
activity in WT mice but did not affect the enzyme activity of the TG animals (Figure 
3.4B).
Hyperoxia and Mitochondrial Defenses Against Oxidative Stress 
MnSOD mRNA Expression.
Since mitochondria are a major source of ROS and free radicals during the exposure to 
hyperoxia, we sought to determine whether cardiac cells had responded to the oxidative 
stress by inducing the expression of mitochondrial SOD antioxidant enzyme (MnSOD) 
(SOD2). We assayed the expression of Mn SOD mRNA, which at baseline (in air) was 
already significantly higher in TG mice than in WT mice. Upon stimulation with 100% 
O2 both WT and TG mice showed a significant increase in MnSOD level. With 
prolonged stimulation for 72 hours the expression of MnSOD dropped in both WT and 
TG but the decrease was more in WT (~ 2.6- fold) than in TG mice (~1.6- fold) (Figure 
3.5).
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Figure 3.1. Identification of mtDNA Deletion in TG Mouse Hearts. SQPCR amplification 
from heart mtDNA of wildtype (WT) and EC-SOD transgene (TG) mice exposed to air 
and hyperoxia (100% oxygen) for 72 hours. The upper band (4669 bp) represents the 
normal mtDNA that amplified by the deletion primers. The lower band (859 bp) 
represents deletion of 3810 bp of mtDNA that was amplified. The deletion was detected 
more in WT (4.8%) than the TG (3.4%) mice after exposure to hyperoxia but the 
difference was not statistically significant.
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Figure 3.2. Mitochondrial Expression of 12S rRNA Transcripts in WT and TG Mouse 
Hearts. Top: 2% agarose gels of RT-PCR. Total RNA was prepared from mice hearts in 
air and after exposure to 100% oxygen for 72 hours. The RNA was reverse transcribed 
with gene specific oligonucleotide primers for mouse mitochondrial 12S rRNA. GAPDH 
mRNA was used as a control for RNA loading and efficiency of RT-PCR. Bottom: 
Densitometry values showing the relative expression of 12S rRNA expressed as mean 
±SEM in air (0 h) and after 72 h exposure to hyperoxia (n = 4 per group*p<0.05).
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Figure 3.3. Nuclear Expression of COX IV mRNA in WT and TG Mouse Hearts. 
Top: 2% agarose gels demonstrating RT-PCR products of nuclear COX IV transcripts 
in WT and TG hearts in air (0 h) and after exposure to 100% oxygen for 72 hours. 
Total RNA was reverse transcribed with gene specific oligonucleotide primers for 
mouse nuclear COX IV. Bottom. Histogram shows the densitometry of COX IV 
mRNA expression normalized to GAPDH from a representative experiment.
Values are expressed as means ± SD of 4 animals/group (*p<0.05).
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Figure 3.4. SOD activity in wildtype and transgenic mouse hearts. (A) The activity of 
EC-SOD in both wild type (WT) and in transgenic mice (TG). (B) The activity of Total 
EC-SOD in wildtype and transgenic mice (B). The activity was measured by inhibition of 
cytochrome c oxidase reduction at pH 10 in air and after 72 hours exposure to hyperoxia 
(100% O2) in 4 mouse hearts pooled /group. One unit of SOD activity is defined as the 
enzyme activity needed to inhibit a 50% reduction in cytochrome c oxidase.
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Figure 3.5. Expression of Mitochondrial SOD (SOD2) mRNA in WT and TG Hearts. 
Top: 2% agarose gel electrophoresis using specific oligonucleotide primers for SOD2 
mRNA in EC-SOD TG mice in air and after 6 and 72 hours exposure to 100% oxygen. 
Bottom: Histogram shows densitometry of the optical density of SOD2 mRNA 
expression normalized to GAPDH mRNA. Values are expressed as means ± SD of 4 
animals/group (*p<0.05).
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Effect of Hyperoxia on Mitochondrial Biogenesis Markers
To test the effect of hyperoxia exposure on stimulating mitochondrial biogenesis, the 
transcription of nuclear respiratory factors NRF-land NRF-2 and their transcriptional co­
activator (PGC-la) was measured. Nuclear respiratory factors are encoded in the nucleus 
and control synthesis of ETC components as well as the transcription of mitochondrial 
transcription factor A (Tfam) which regulates transcription and replication of the 
mitochondrial genome.
NRF-1 mRNA expression
The expression level of NRF-1 mRNA was measured using RT-PCR. The message was 
normalized to the nuclear encoded gene GAPDH. The expression of NRF-1 in air-control 
mice between WT and TG groups was similar. On exposure to oxygen for 6 hours, both 
WT and TG mice showed an increase in NRF-1 but the expression was most significant 
in TG mice (79%, ~ 1.8-fold, p<0.05). With prolonged O2 stimulation for 72 hours the 
expression level in TG mice remained elevated, while in WT mice it decreased by 64% 
compared to air- control (Figure 3.6A).
NRF-2 mRNA expression
The relative mRNA expression for NRF-2 in air-control groups was about two-fold 
higher in TG mice than in WT animals. After 6 hours of exposure to hyperoxia the 
expression increased by 80% in WT but in TG mice the increase in mRNA was not 
statistically significant. However after 72 hours of exposure the expression was 
significantly increased in TG mice by 64% (~ 1.64-fold) compared to the WT mice and
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this difference in NRF-1 expression between the TG and the WT groups was highly 
significant (p<0.05). This result showed that the TG mice have a higher basal level of 
NRF-2 expression than the WT and the cardiac expression of NRF-2 can be highly 
stimulated in the TG mice by O2 exposure (Figure 3.6B).
Tfam mRNA expression
Because Tfam plays an important role in regulating mitochondrial replication and 
transcription, the level of Tfam transcripts was measured. The expression of Tfam mRNA 
in TG mice in air (normal oxygen) was significantly increased by 20% compared with the 
WT group. On stimulation with 100% oxygen for 6 hours the mRNA expression in both 
WT and TG mice decreased but only the decline in TG mice (by 61%) was significant. 
With prolonged O2 stimulation for 72 hours the Tfam expression in TG mice increased 
back to normal levels, (Figure3.6C). The persistent decrease in Tfam expression in WT 
mice indicates that oxidative stress was more pronounced in the WT mice than the TG 
mice and that oxidative stress affects nuclear genes essential for mitochondrial 
biogenesis.
PGC-1 alpha mRNA expression
Because PGC-1 a is a master regulator of mitochondrial biogenesis through co-activation 
of nuclear transcription factors (NRF-1 and 2), we wanted to know if the increase in 
expression of NRF-1 and NRF-2 after exposure to hyperoxia was associated with an 
increase in expression of PGC-la. The expression of PGC-la mRNA increased by -1.8- 
fold (78%) in WT and -  2-fold in TG mice after O2 exposure for 6 hours compared with
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
46
air-control group (p<0.05). With prolonged hyperoxia exposure for 72 hours, PGC-la 
mRNA expression was increased by 60% in TG mice but decreased dramatically in WT ~
2.6-fold (Figure3.6D). The increased transcription of PGC-la with coordinate expression 
of the downstream genes, NRF-1 and NRF-2, is consistent with the role PGC-1 a as an 
important nuclear regulator of respiratory gene expression.
Effect of Hyperoxia on Mitochondrial Biogenesis and Cell Survival 
Akt protein expression
Because PGC-la expression was up regulated in EC-SOD- TG mice after hyperoxia, as 
was expression of NRF-1 and NRF-2, we were interested in finding the signal that could 
induce the expression of NRF-1, NRF-2 and PGC-1 a. Because the murine NRF-1 
peptide sequence has an Akt phosphorylation motif (RXRXX (S/T) at position 104-109, 
we assessed Akt activation by immunoblot analysis using anti-Akt and anti-phospho-AkT 
antibodies. For animals exposed to normal air, the expression level of a 60 KD protein 
band of pAkt in TG mice was -1.46 fold (p<0.05) higher than WT mice. After 6 hours of 
hyperoxia, p-Akt expression was increased in both WT and TG, but the expression was 
marginally increased in TG than the WT. After 72 hours, both WT and TG Akt level 
dropped below air-control levels but the level in TG mice was still higher than in WT 
(Figure 3.7). These results showed that Akt was activated early after oxidative stress in 
the mouse heart and may be the activator for transcription ofNRF-1 after hyperoxia 
exposure.
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Figure 3.6. Nuclear Markers for Mitochondrial Biogenesis in WT and TG Mouse Hearts. 
The histogram shows the relative mRNA expression of mitochondrial biogenesis 
markers; nuclear respiratory factors (NRF-1 and NRF-2 (A&B)), mitochondrial master 
regulator PGC-la (C) and mitochondrial transcription factor A, Tfam in (D), in WT and 
EC-SOD TG mice hearts. The mice groups were exposed to room air (0 h) and after 6 
and 72 hours to 100% oxygen. The densitometry values normalized to GAPDH mRNA 
expression. Values are expressed as means ± SD of 4 animals/group (*/K0.05).
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MAPKp38 protein expression
The activation of p38 by cytokines has been reported to activate PGC-la [75].Therefore 
we were interested to determine the effect of hyperoxia on p38 in TG mouse heart. The 
activation of p38 was measured by Western blot using antibodies to phosphoiylated-p38 
(p-p38). The p-p38 expression was normalized to total p38. At baseline p-p38 protein 
expression was significantly higher in TG hearts than in WT mice (100%). After 6 hours 
of exposure to 100% oxygen, WT mice showed a 2.5 fold increase in p-p38 expression 
but the TG mice showed no significant change. With prolonged O2 stimulation, the p-p38 
expression level dropped by 50% in TG and WT hearts (Figure 3.8). This result showed 
that cardiac p38 was not activated in TG mice heart by stress with hyperoxia. In contrast, 
the WT mice had higher p38 activation after 6 hours, suggesting that the cells could be 
more likely to undergo apoptosis after prolonged oxygen exposures.
CAMKIV expression
Because Ca2+ /calmodulin kinase (CAMK) is known to increase expression of the 
respiratory genes and PGC-la and therefore mitochondrial biogenesis, we investigated 
the effect of exposure to hyperoxia on the activation of CAMK in TG mice 
cardiomyocytes. The protein expression of CAMKIV was assessed by Western blot 
analysis. We found that expression of cardiac CAMKIV was significantly higher in TG 
mice hearts than in WT in the basal line (air control) and after short term and long term 
exposure to hyperoxia (p<0.05) (Figure 3.9).
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Figure 3.7. Western Blot Analysis of Cardiac p-Akt in TG and WT Mouse Hearts. 
Western blot were performed using 20 pg of total heart cellular protein of TG (top) and 
WT (bottom) and antibody to p-Akt. Total Akt antibody was used as internal control. The 
protein expression was measured in air (0 h), after 6 hours, and after 72 hours exposure to 
hyperoxia (100% O2). Histogram shows densitometry values for p-Akt/Akt as means ± 
SD of 5 animals/group (*p<0.05).
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Figure 3.8: Western Blot Analysis of Cardiac p38 in TG and WT. Top, immunoblot 
shows protein expression of phosphorylated p38 in EC-SOD TG and WT mice hearts in 
air (Oh), and after 6h and 72h exposure to 100% oxygen using specific p-p38 antibody. 
Phosphorylated-p38 was normalized to the expression of total p3S.Bottom. Histogram 
showing densitometry data expressed as mean ± SED of 3 animal/group (*p<0.05).













Figure 3.9. Western Blot Analysis of Cardiac CAMKIV Expression in TG and WT 
Mouse Hearts. Top, Immunoblot shows protein expression of cardiac CAMKIV in EC- 
SOD TG and WT mouse hearts in air (0 h), after 6 h and after 72 h exposure to 
hyperoxia. The expression level was normalized to tubulin protein expression. Bottom, 
Densitometry data was expressed as mean ± SD of 5 animals/group (*p<0.05).
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Effect of Hyperoxia on Cardiac Muscle Survival
Alpha actinin (a-actinin) is the major structural components of sarcomeric Z-lines of 
striated muscle. To define if the damage by oxidative stress affects cardiac muscle 
integrity, a-actinin protein expression was measured by Western blot. Expression of a 
100 KDa band was detected and analyzed by densitometry and normalized to tubulin 
protein. The a-actinin expression was higher in TG cardiac mice in air control compared 
with the wild type mice. After 72 hours exposure to 100% O2, a-actinin expression 
increased in both TG and WT cardiac muscle and the increase was significant in both 
groups (/?<0.05) (Figure 3.10).
p-Badprotein expression.
We investigated whether Bad protein is activated after exposure to hyperoxia. The 
expression of 45 KDa phospho-Bad (p-Bad) was assayed by Western blot. The 
expression level was analyzed by densitometry and normalized to tubulin protein. The 
expression of p-Bad in TG hearts in air-control mice was significantly higher than in WT 
air-control mice. After oxygen exposure for 72 hours, cardiac p-Bad expression increased 
by 8-fold in WT mice, but only by 1.3 fold in TG mice compared to the air-control group 
(Figure 3.11). This result showed that EC-SOD TG mouse hearts have a high continuous 
expression of p-Bad at the baseline and that it responds to stimulation by oxygen. This 
could explain why these mice are better protected than WT mice from oxidative stress 
that leads to apoptosis.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
53
p-GSK-3p protein expression
We found no significant difference in the expression of p-GSK-3p between TG mice in 
air-control and after exposure to hyperoxia. However, WT mice showed a 3.7 fold 
increase in p-GSK-3p expression after exposure to hyperoxia. The expression was also 
highly significant between the WT and TG mice after hyperoixa (p<0.05) (Figure 3.12).
Part 2: Effect of Hyperoxia in EC-SOD Knockout Mice (KO)
The EC-SOD KO mice were bred on a C57/BL6-J background strain. Therefore the wild 
type C57/BL6-J strain was used as control group for the KO mice experiments. EC-SOD 
KO mice are phenotypically the same as the wild type mice and they lived to the same 
age as the wild type mice (-18 months). On exposure to hyperoxia (100% oxygen ), they 
behaved differently: after 24 hours the mice started to huddle together, and after 48 hours 
developed signs of respiratory distress, and some died during the exposure.
Hyperoxia and mortality
Hyperoxia was lethal to 10% of the exposed WT mice (2/20), and was more 
lethal to the exposed KO mice (6/24, 25%). The mortality occurred between 48 and 72 
hours of exposure, Table 3.4. Exposure to 100% oxygen increases formation of reactive 
oxygen species which may cause oxidative damage to the organs. The lung and heart are 
especially sensitive and may progress to cardiac and pulmonary failure.
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Figure 3.10. Alpha-Actinin Protein Expression in TG Mouse Hearts, a-actinin is a marker 
for cardiac muscle integrity. Expression of a-actinin in EC-SOD TG and WT mouse 
hearts was measured by Western blot analysis using specific a-actinin antibody. The 
relative expression of a-actinin was normalized to tubulin protein expression. The 
histogram shows the densitometry data of a-actinin /tubulin expressed as mean ± SD of 5 
animals/group (*p<0.05).
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Figure 3.11. Protein Expression of p-Bad in TG Mouse Flearts. Bad is a marker for 
apoptosis, protein expression for phosphorylated Bad (p-Bad) in EC-SOD TG and WT 
mouse hearts was measured by Western blot analysis using p-Bad antibody. The 
expression was measured in basal line (air), and after 72 h exposure to hyperoxia. The 
protein expression was normalized to tubulin expression. Densitometry data of p- 
Bad/tubulin was expressed as mean ± SD of 5 animals/group (*/?<0.05).
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Figure 3.12. Protein Expression p-GSK-3P in TG Mouse Hearts. Glycogen synthase 
kinase-3p (GSK-3P) is a pro-apoptotic protein. Expression of p-GSK-3p in EC-SOD TG 
and WT mouse hearts was measured by Western blot using p-GSK- 3p antibody. The 
expression was measured in air and after 72 hours exposure to hyperoxia. P-GSK-3P 
protein expression was normalized to tubulin protein expression. Densitometry data of p- 
GSK-3p/tubulin was expressed as mean ± SD of 5 animals/group (*/><0.05).




The discussion is divided into three parts: Part 1 discusses and interprets the studies on 
EC-TG mice; Part 2 does the same for the EC-SOD KO mice data; Part 3 is a general 
discussion and integration of both the TG and the KO mouse data sets. Both sets of 
experiments used hyperoxia (100% O2 by inhalation) at early and late (6 and 72 h) time 
points. There were, however, initial differences between the two strains of genetically- 
altered mice relative to the appropriate wild type strains that resulted in some important 
differences in baseline cardiac gene expression. These differences had never been 
characterized previously and probably contributed to the observed strain differences in 
survival in hyperoxia (see again Table 3.1).
Part 1: Discussion for EC-SOD TG Mice Data
This study demonstrated for the first time that prolonged exposure to 100% O2 by 
inhalation causes changes in gene expression that indicate mitochondrial oxidative stress. 
Most notable was the presence of a small amount of 3810 bp deletion in the mtDNA of 
the mouse heart. The amount of deleted cardiac mtDNA (3.4%) in the TG mouse was less 
prominent than that in WT hearts (4.8%). This oxidant- sensitive mtDNA deletion has 
been reported earlier in the rat liver and heart after exposure to LPS and hemin [21, 72, 
76]. The large deletion (3810 bp) in the mitochondrial genome includes codons for 
NADH dehydrogenase (ND1 and ND2), cytochrome c oxidase (COX I), 16S rRNA and 
six tRNAs for amino acids. Mitochondria carrying this deletion in sufficient copy number
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would have both impaired entry of reducing equivalents into the respiratory chain at 
Complex I and alterations in the capacity to reduce O2 at Complex IV. This deletion is 
mostly accompanied by the accumulation of substantial 8-hydroxyguanine [72] initiated 
by oxidation of DNA bases by f^Oi-catalyzed hydroxylation and other strong oxidants 
[77-79]. Because mitochondrial DNA is a naked double-stranded circular DNA molecule 
and because of its low proofreading efficiency and insufficient repair during replication, 
it is vulnerable to oxidative damage and mutations [80].
Overexpression of an extra copy of EC-SOD in TG mice increased the activity of 
EC-SOD in TG mice hearts by 2-fold (Figure3.4) over WT. Moreover, the primary 
antioxidant enzyme in mitochondria, SOD2 was also increased «2 fold in TG mice 
compared to the WT mice after hyperoxia exposure. The reason for the SOD2 response is 
unclear and is unexpected. However, the increase in SOD2 and SOD3 activity in the TG 
mice provide an explanation for the attenuated damage to the mitochondria after 
hyperoxia exposure compared to WT mice. Thus, the link between extracellular and 
mitochondrial defensive mechanisms could be directly involved in the protection of cells 
and organelles from oxidative damage. The increase in EC-SOD and MnSOD expression 
in TG are most responsible for elimination of hyperoxia induced ROS production and 
decreased formation of superoxide and peroxynitrite anion (ONOO’).
The significant decrease (29%) in mitochondrial expression of 12S rRNA in WT 
hearts after hyperoxia compared to TG mice suggests that either mtDNA in TG mice is 
relatively undamaged compared with WT hearts and /or the transcriptional machinery or 
the transcriptosome in the TG cardiac mitochondria is not affected by exposure to 
hyperoxia. Because Tfam is an essential component of the mitochondrial transcriptosome
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as well as necessary for mtDNA replication and genome maintenance, we investigated 
cardiac mRNA expression levels for Tfam before and after oxygen exposure. Tfam 
mRNA expression was significantly increased in TG hearts with long term exposure by
1.6-fold but decreased in WT hearts, which is consistent with the decrease in 12S rRNA 
expression. This finding supports the notion that low Tfam levels stimulate mtDNA 
replication while higher levels stimulate transcription [81]. In addition, these data provide 
significant evidence that increases in the extracellular antioxidant EC-SOD can influence 
mitochondrial function and biogenesis in response to direct oxidative insults such as 
hyperoxia. The increase in the nuclear expression of cytochrome c oxidase (COX IV) 
mRNA after exposure to hyperoxia in TG hearts by 40% with no change in WT indicates 
that the nucleus in the TG mice has responded positively to the oxidative damage that 
targets the mitochondria. Additionally, an earlier study showed that COX IV expression 
in cardiomyocytes of WT mice is an early event that peaked by 6 hours and goes down 
to 40- 50% by 72 hours (Suliman, unpublished data). This data may explain the blunted 
response of COX IV expression in WT hearts after 72 hours of hyperoxia.
The recovery of mitochondrial damage by biogenesis requires coordinated 
activation of transcription factors and binding to promoter consensus sequences in 
nuclear genes encoding for mitochondrial proteins [82]. NRF-1, NRF-2, SP1 and PGC- 
la, Tfam, mTFBl and mTFB2 are the relevant transcription factors and cofactors 
involved in mitochondrial biogenesis that have been identified to date [83]. In response to 
biogenesis-inducing stimuli, transcription for these proteins changes before or coincident 
with increases in the expression of their target genes [82]. The data presented here 
showed that hyperoxia increased mRNA expression of PGC-la, NRF-1 and NRF-2 as
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well as Tfam expression concurrently in TG hearts. However, in the WT control group, 
although there was an early increase in the mRNA expression of PGC-la, NRF-1 and 
NRF-2, and this response did not persist with prolonged hyperoxia as in TG mice. 
Because the promoter region of Tfam has consensus motifs recognized by NRF-1 and or 
NRF-2 upstream of the transcription machinery [84], the decrease in NRF-1 and NRF-2 
may explain the down regulation of Tfam transcripts in the WT hearts. Cooperation 
among DNA-binding proteins and promoter diversity among nuclear genes for 
mitochondria regulate biogenesis [85]. PGC-la has a major impact on the NRF system, 
and transfection of PGC-la in muscle cells dramatically induces gene expression for 
NRF-1, NRF-2, and Tfam. Furthermore, PGC-la physically interacts with NRF-1 and co- 
activates its transcription activity [11]. Because PGC-la promoters have multiple sites 
for redox-sensitive transcription factors, e.g., CREB and API [86, 87], oxidant regulation 
of PGC-1 a should co-activate NRF-1 and NRF-2 simultaneously, which are also 
oxidant-sensitive transcription factors. Furthermore, mutations that affect PGC-la 
expression lead to loss of heart mitochondria and down regulation of mitochondrial 
enzymes [13]. Interestingly, PGC-la has been also shown to be induced in brown fat 
cells on cold stimulation, suggesting that PGC-la strongly co-actives several nuclear 
receptors (PPAR gamma, PPAR alpha, RAR and TR) that bind to mitochondrial 
uncoupling protein-1(UCP-1) enhancer [12]. So PGC-la in cardiac cells regulates several 
genes of the electron transport chain, mitochondrial biogenesis, and fatty acid 13- 
oxidation. Effective cardioprotection would require not only cardiomyocyte survival but 
also preservation of function. Acute activation of PI3-kinase or Akt is sufficient to inhibit 
cardimyocyte apoptosis [88], but more importantly, acute activation of Akt also preserves
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function in surviving cardiomyocytes [89]. In cardiomyocytes, IGF-1 activates PI 3- 
kinase /Akt signaling pathway, which appears largely necessary to reduce hypoxia- 
induced apoptosis in cardiomyocytes in vitro [88]. In this study, acute activation of Akt 
(at 6 hours) by hyperoxia in both WT and TG hearts provides direct evidence that the PI 
3-k/Akt pathway was a protective response induced by high oxygen exposure (100% O2). 
The exact mechanism that activates PI3k/Akt pathway in hyperoxia is not yet delineated. 
However, the increase in activity of EC-SOD may contribute to increased dismutation of 
.0~2 to H2 O2 which could mediate the activation of the PI3k/Akt pathway [90]. Greater 
Akt activation in EC-SOD TG mice than in WT mice after hyperoxia may indicate either 
that Akt activation is stimulated by the production of more H2O2 by extra EC-SOD 
enzyme or that TG mice have less oxidative damage so the activation of the pro-survival 
pathway is more evident.
The acute increase in Akt was coincident with an increase in PGC-la, and NRF-1 
mRNA expression, suggesting that PGC-la and NRF-1 are activated by Akt in our mice 
after hyperoxia. This stimulation of mitochondrial biogenesis markers confirms that Akt 
has an important role in promoting cell survival. Besides its effect as a pro-survival 
factor, Akt has also been found to restore cardiac function in normal and failing heart 
most probably by increasing SERCA phosphorylation by Akt which enhances calcium 
mobilization in the heart [91]. Additional molecular work will be needed to determine if 
Akt activation by oxygen leads to phosphorylation and nuclear translocation of NRF-1 
and PFC-la.
Akt also plays an important role in inhibiting apoptosis: adenoviral expression of 
constitutively active mutants of either PI 3-k or Akt reduces hyperoxia-induced apoptosis
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in cardiomyocytes in vitro [88]. Multiple anti-apoptotic downstream effectors of Akt 
have been identified. Phosphorylation of the pro-apoptotic Bel family protein, Bad, has 
been reported to mediate anti-apoptotic signaling [33, 92]. Also phosphorylation of 
caspase -9 by Akt inhibits its activity [93]. Phosphorylation of the Forkhead transcription 
factors, F0X03a, by Akt induces nuclei exclusion and reduces transcription of specific 
pro-apoptotic molecules [94]. In our study, a concomitant increase of p-Akt and pBad in 
the TG hearts at base line in air-control group (~ 4-fold in pBad) substantiates the 
Akt/Bad pathway activation in these TG mice and implies that they are better protected 
from apoptotic cell death. Also in our study, increased phosphorylation of glycogen 
synthase kinsae-3P (GSK-3p) in TG mice in the air control and after hyperoxia groups is 
an indication that Akt/GSK signaling pathway is activated. Phosphorylation of GSK-3P 
by Akt inactivates GSK-3P and leads to inhibition or delayed activation of the 
mitochondrial permeability transition, a key regulator of apoptosis. Also, it is reported 
that overexpression of catalytically active GSK-3P induces apoptosis, whereas expression 
of a dominant-negative prevents apoptosis after inhibition of PI-3K [95].
Activation of the Akt signaling pathway by adrenomedullin (a potent vasoactive 
peptide) protects against cardiomyocyte apoptosis induced by ischemia/reperfusion injury 
through the Akt-GSK caspase signaling pathway [96]. It is also reported that increased 
Akt activity inactivates GSK-3P and downregulates caspase 3- activity and decreases 
apoptosis in cardiomyocytes. Other studies have shown drugs that inhibit GSK-3P are 
cardioprotective [97, 98] and appear to mediate cardioprotection by phosphorylation of 
GSK-3P [40]. These studies support our finding that increased phosphorylated GSK-3P in 
EC-SOD mice hearts mediate cardioprotection.
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Negative regulation of Akt in the heart is important, because continuous 
activation of Akt is sufficient to induce substantial cardiac hypertrophy [99, 100]. Akt is 
inactivated either through inhibition by PTEN, which inhibits PI3-k /Akt signaling 
pathway[101-103] or through dephosphorylation of Akt itself by phosphatase, PP2A 
[104]. Such negative regulation might explain the decrease in the expression of Akt after 
72 hours exposure to hyperoxia that we found in TG mice. This will require additional 
work.
Because p38 is a stress kinase that is cell type and stimulus dependent, its 
signaling has been shown to promote cell death in some cell lines, while in other cell 
lines it enhance survival, cell growth and differentiation. In the heart, activation of p38 is 
accompanied by cardiomyocyte hypertrophy. Also because p38 functions upstream and 
downstream of caspases in apoptosis its activation can promote apoptosis [105, 106]. 
Activation of p38 in this study by hyperoxia was significantly increased in the WT mice 
hearts after only 6 hours of exposure. While the MAPK p38 pathway did not change in 
the TG mice after 6h of hyperoixa, it decreased afterwards. Decreases in p38 activation in 
TG hearts after hyperoxia exposure indicates that p38 apoptotic pathway is not activated, 
and these mice should be protected from apoptosis.
This study provides the first evidence that overexpression of extracellular 
antioxidant enzyme EC-SOD protects an intracellular organelle, the mitochondria, from 
oxidative stress. Also TG mice respond to oxidative stress induced by hyperoxia through 
activation of the cell survival pathway mediated by PI3k/Akt signaling pathway. 
Moreover, the important role of Akt in promoting cell survival appears to be mediated via
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activation of all or part of the mitochondrial biogenesis pathways and inhibition of pro- 
apoptotic pathways.
Part 2: Discussion for EC-SOD KO Mice Data
Mitochondrial DNA (mtDNA) deletions have been shown to increase with aging 
and ischemia as a result of oxidative stress, and are suggested to contribute to myocardial 
dysfunction [14,107]. In this study we demonstrated that hyperoxia induces 
mitochondrial DNA deletion in KO mouse hearts. Accumulation of ROS during 
hyperoxia exposure in these KO mice may be the direct cause of this mtDNA deletion. 
The deleted part of the mitochondrial genome (3810 bp) constitutes about 23% of the 
total mtDNA genome (16459 bp). Because the 3810 bp deleted portion of mitochondrial 
genome includes codons for NADH dehydrogenase (ND1 and ND2), cytochrome c 
oxidase (COX I), 16S rRNA and six tRNAs mitochondria carrying this deletion in 
sufficient copy number will have changes in the OXPHOS system, which further 
amplifies ROS formation and diminishes production, and may predispose to heart failure. 
The high mortality rate (25%) among the EC-SOD KO mice after prolonged continuous 
hyperoxia may be due to lung or cardiac damage or both, caused by excessive ROS 
formation. Oxygen itself is implicated because the heart mitochondria manifested an 
increased mtDNA deletion in cardiomyocytes (24%), especially in EC-SOD KO mice. In 
otherwords, the absence of EC-SOD probably led to accumulation of overwhelming 
levels of ROS (.O2’) after exposure to hyperoxia that influenced not only the extracellular 
milieu but also the mitochondrial compartment, either directly or indirectly, causing 
appreciable oxidative damage to mtDNA. Deletion of mtDNA had been found in tissues
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of coronary artery disease patients [108]. The increased oxidative stress in cardiovascular 
disease especially from transient episodes of ischemia may be responsible for the 
accumulation of mtDNA damage in these patients.
When mitochondrial gene transcription was measured using RT-PCR, we found 
that the transcript for 12S rRNA in KO compared to the WT hearts was decreased at 
baseline in air control mice. Thus, lack of EC-SOD not only affects the mitochondrial 
compartment during hyperoxia but also under normal conditions. This decrease in 12S 
rRNA in EC-SOD KO mice is most probably due to oxidative damage to mtDNA which 
affects transcription of its genes. In contrast, expression of nuclear gene COX IV was 
similar between the KO and WT mice at baseline. These findings confirm that the 
mtDNA genome is more sensitive to oxidative damage than the nuclear genome in the 
heart, especially in the absence of EC-SOD.
Expression of the mitochondria antioxidant SOD2 (MnSOD) was also affected 
during hyperoxia. At baseline the expression was higher in the KO mice compared to the 
WT, perhaps to compensate for the absence of EC-SOD. However, SOD2 expression 
decreased dramatically (~ 4.5 fold) after a 6 hour exposure to hyperoxia in both the WT 
and KO mice. The exact mechanism responsible for this finding is not yet identified. 
However, this phenomenon might be due to the increased CpG islands in the promoter 
region of MnSOD and the susceptibility of these islands to oxidative stress induced 
methylation, thus silencing of the gene. The CpG is a C+G rich area span >3.5 Kb near 
the 5' edge of the SOD2 promoter region and extends into intron 2. Increased cytosine 
methylation in this area induces epigenetic silencing of MnSOD gene expression. This 
mutation has been found in many tumor cell lines, e.g myeloma cell line KAS 6/1 [109].
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Increased ROS formation in malignant cells or in hyperoxia exposure may lead to this 
methylation. Enforced expression of SOD2 in many transformed cell has been associated 
with suppression of the malignant phenotype of the transformed cells, suggesting that 
SOD2 is also a tumor suppressor gene via protection of the mitochondrial compartment 
[110].
In this study we also showed that nuclear respiratory factors, NRF-1 and NRF-2, 
which regulate mitochondrial biogenesis, are stimulated early by hyperoxia in KO mouse 
hearts but not the WT. The cardiac mRNA expression of NRF-1 and NRF-2 in WT mice 
was inversely related to prolonged exposure to hyperoxia compared with that in the EC- 
SOD KO mouse hearts. Excessive ROS production in KO mice may be the signal to 
increase expression of these nuclear respiratory factors. Unexpectedly, the increase in 
mRNA of NRF-1 and NRF-2 in KO mice after 6 hours exposure to hyperoxia was not 
associated with an increase in PGC-la protein expression, a known nuclear receptor and 
co-activator of NRF-1 [111]. Moreover, in addition to the decrease in PGC-1, the 
decrease in activated Akt, phosphorylated Bad and GSK proteins in the KO mice after 
hyperoxia imply that early expression of NRF-1 and NRF-2 in the KO mice was not due 
to activation of Akt and not associated with PGC-1. The decrease in Tfam expression 
after exposure for 6 hours in both KO and WT may be also due to methyaltion of the 
NRF-1 binding site of the Tfam promoter, therefore suppressing Tfam expression and 
decreasing mitochondrial biogenesis, as was reported by another group [112].
There are many links between Ca2+ and respiratory gene expression mediated by 
Ca2+ -dependent regulatory enzymes, Ca2+/calmodulin-dependent protein kinase 
(CAMK) and protein kinase C (PKC). It was reported that calcium ionophores lead to
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increase of cytochrome c gene expression through a Ca2+ -sensitive and PKC-dependent 
pathway [113]. Activation of CAMKIV due to changes in intracellular Ca2+ [16] and 
activation of AMP kinases due to change in ATP/AMP ratio [114] can lead to an increase 
in mitochondrial abundance. Our data on CAMKIV protein showed no significant change 
in the expression in the KO or in the WT mice before or after exposure to hyperoxia, 
which disqualifies the involvement of this pathway in activation of NRF-1 and NRF-2 in 
this study.
The mitogen-activated protein kinase p38 is activated by cellular stressors in the 
heart, including ischemia, hypoxia, and hypertrophic growth stimuli. The role of p38 -  
MAPK in hyperoxia is not yet well understood and its role in myocardial ischemia- 
reperfusion injury is controversial. Several lines of evidence suggest that the activation of 
p38-MAPK/MAPKMAPK2/Hsp-27 axis contributes to ischemic preconditioning. 
However, others have concluded that p38-MAPK inactivation might be cardioprotective 
[115]. The different results might be due to the existence of two p38-MAPK isoforms (a 
and (3) in the heart: while p38a transmits pro-apoptotic signals, p38(3 triggers a 
hypertrophic response and promotes survival [116]. Our findings showed that p38 was 
activated in KO mice after hyperoxia, which is consistent with the activation of NRF-1 
and NRF-2. Activation of the nuclear respiratory factors here may suggest that the p38[3 
is activated and this stimulated the pro-survival pathway. P38 was also activated in WT 
mice after 6 hours exposure to hyperoxia but had decreased significantly by 72 hours. In 
the heart, activation of p38 had been implicated in increased mitochondrial biogenesis 
and energy levels in the cell through phosphorylation of peroxisome proliferative- 
activated receptor alpha (PPARa) and its co-activator PGC-la [117]. The p38 isoforms
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need to be further defined in these KO and WT mouse hearts in order to discern the effect 
of p38 on cell survival during hyperoxia.
The decrease of p-Bad and pGSK-3p expression after hyperoxia was more 
prominent in the EC-SOD KO mice, consistent with decreased activation of Akt. 
However, Akt was activated in the WT after 6 hours and was accompanied by 
phosphorylation of BAD and no significant change in GSK-3J3. The responses to 
hyperoxia in these two groups were different, as was the subsequent activation of cell 
signaling pathways.
Our results indicate that EC-SOD KO mice are more susceptible to oxidative 
mtDNA damage and mtDNA deletion than the WT control. In the absence of EC-SOD, 
the activation of mitochondrial biogenesis in response to hyperoxia most probably 
happens not through Akt, but may involve the activation of p38 MAPK. However, the 
exact outline of the p38 activation pathway can not yet be drawn, but there may be 
excessive oxidative stress which leads to decreased mitochondrial energy production.
This could decrease the ATP/AMP ratio and thereby stimulate cAMP, which would also 
activate p38. This possibility will require further study. Also the decreased expression of 
p-Bad and p-GSK-3(3 in KO mice after hyperoxia may suggest that the hearts of these 
mice are more likely to undergo apoptosis, which needs to be evaluated specifically, 
using cell death analysis in a future study.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
93
Part 3: General Discussion, Conclusions and Further Directions
This study has four main new findings. First, EC-SOD TG mice have a higher 
tolerance to hyperoxia exposure than KO mice. Oxygen toxicity was manifest as 
increased respiratory distress and an increased mortality rate in the KO mice. Second, 
EC-SOD KO mice were more sensitive than TG mice to cardiac oxidative damage which 
appeared as an increase in the extent of mtDNA deletions (23%) vs (3.4%). Third, 
transcription of mitochondrial and nuclear genes decreased after exposure to hyperoxia in 
KO mice in the some genes (12S rRNA, COX IV, SOD2, PGC-1, and Tfam) in contrast 
to TG mice where the transcription increased after hyperoxia exposure. Fourth, there 
were basal differences in cardiac mitochondrial gene expression in the genetically altered 
EC-SOD mouse strains.
The absence of the EC-SOD enzyme in KO mice may increase formation of 
reactive oxygen species (ROS) such as superoxide anion, hydroxyl radical and 
peroxynitrite. ROS oxidatively damages mtDNA, and also affects mitochondrial and 
nuclear mRNA expression. Because ROS are produced locally in the mitochondria by 
leakage from electron transport and because mtDNA repair mechanisms are less efficient 
than nuclear DNA repair mechanisms, a significant deletion or mutation in mtDNA can 
affect mitochondrial respiration, and ATP production rates. This would decrease 
cardiomyocyte function, which may lead to cardiac failure. A number of recent clinical 
studies have reported reduced levels of human extracellular superoxide dismutase in 
patients with cellular artery disease and myocardial infarction [118-120]. In Denmark, 2- 
3% of the population carries a mutation in the EC-SOD gene (R213G) which results in 
increased plasma concentration of EC-SOD enzyme and reduced arterial wall EC-SOD
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concentration, and is associated with elevate risk for ischemic heart disease. [58]. 
Moreover, experience with EC-SOD gene therapy has been reported to protect the 
myocardium against experimental episodes of ischemia/reperfusion injury [121,122].
Mitochondrial biogenesis markers NRF-1, NRF-2, Tfam, and PGC-la were up- 
regulated in TG mice after short term exposure to hyperoxia. In KO mice, the NRF-1 and 
NRF-2 increased after short term exposure to hyperoxia but Tfam and PGC-1 expression 
increased after long term exposure to hyperoxia. The upstream signal for activation of 
mitochondrial biogenesis most probably was through Akt activation in TG mice but this 
could not be supported in the KO mice. Akt was not activated in the KO but the 
stimulation of the nuclear respiratory factors was, and possibly through activation of p38. 
Because we did not study p38 isoforms, it is not known for sure that activation of p38 
found in the heart was either the signal for survival (p38 P) or apoptosis (p38a). 
However, a decrease in pBad expression and pGSK-3p in KO mice after hyperoxia 
exposure suggests that these mice are more likely to have cardiomyocyte apoptosis 
during oxidative stress.
Conclusions: Systemic hyperoxia consistently increases mitochondrial biogenesis 
markers in the mouse heart, most prominently in EC-SOD TG mice, and co-incidentally 
with increases in Akt, CAMK, p-Bad and p-GSK-3p. This suggests that extracellular 
ROS, most likely hydrogen peroxide, activate mitochondrial biogenesis and the pro­
survival pathway in TG mice. On the other hand, the presence of the transgene may allow 
augmentation of nitric oxide (NO bioactivity) to stimulate biogenesis, e.g. through cyclic 
GMP-mediated effects. This possibility was not explored. Also, hyperoxia decreased the 
activation of Tfam and PGC-la transcription after 6 hours and increased it again after 72
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hours in KO mice. This was associated with decreased expression of Akt, CAMK, p-Bad 
and p-GSK-3|3 and an increase in p38, indicating that either hyperoxia activated 
mitochondrial biogenesis and pro-survival pathways through p38 or that hyperoxia 
produced more oxidative damage to the mitochondria in the KO. In the latter case, the 
increase in p38 may be a signal for activation of apoptotic pathways. These unexpected 
findings in KO mice need further exploration in the future.
Further Directions:
The following studies should help further elucidate the mechanisms by which EC-SOD 
protects the heart from hyperoxia and other types of extracellular oxidative stress.
1-Examine the TG and KO mouse heart tissues for evidence of apoptosis by TUNEL and 
DNA laddering.
2- Measure caspase -3 and cytochrome c activity to assess mitochondrial initiation of 
apoptosis.
3- Measure the expression of p38 isoforms in the hearts in the TG and KO mice to 
evaluate the possible protective activation of this signaling pathway during hyperoxia 
stress.
4- Measure ANF as a marker for cardiac hypertrophy and functional impairment.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
96
REFERENCES
1. Naug, H.L., Browning, J., Gole, G.A., and Gobe, G. (2000). Vitreal macrophages 
express vascular endothelial growth factor in oxygen-induced retinopathy. Clin. 
Experimen. Ophthalmol. 28,48-52.
2. Donzelli, S., Espey, M.G., Tomas, D.D., Mancardi, D., and et al. (2006). 
Discriminating formation of HNO from other reactive nitrogen oxide species.
Free Radic. Biol. Med. 40, 1056-1066.
3. Williams, R. (2000). Canaries in the coal mine: mitochondrial DNA and vascular 
injury from reactive oxygen species. Circ. Res. 86, 915-916.
4. Sawyer, D.B., and Colucci, W.S. (2000). Mitochondrial oxidative stress in heart 
failure: "Oxygen wastage" revisited. Circ.Res. 8 6 ,119-120.
5. Ballinger, S.W., Patterson, C., Yan, C.N., and et al. (2000). Hydrogen peroxide 
and peroxynitrite-induced mitochondrial DNA damage in vascular endothelial and 
smooth muscle cells. Circ. Res. 86, 960-966.
6. Hudson, E.K., Tsuchiya, N., and Hansford, R.G. (1998). Age-associated changes 
in mitochondrial mRNA expression and translation in the Wistar rat heart.
Mech.Ageing Dev. 103, 179-193.
7. Clayton, D.A. (2000). Transcription of mammalian mitochondrial DNA genome. 
Annu. Rev. Biochem. 53, 573-594.
8. Wallace, D.C. (1999). Mitochondrial diseases in man and mouse. Science 283, 
1482-1488.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
97
9. Choksi, K.B., Boylston, W.H., Rabek, J.R., Widger, W.R., and Papaconstantinou, 
J. (2004). Oxidatively damaged proteins of heart mitochondrial electron transport 
complexes. Biochim. Biophys. Acta 1688, 95-101.
10. Kinugawa, S., Tsutsui, H., Satoh, S., and et al. (1999). Role of Ca2+ availability to 
myofilaments and their sensitivity to Ca2+ in myocyte contractile dysfunction in 
heart failure. Cardiovascular Research 44,398-406.
11. Wu, Z. (1999). Mechanisms controlling mitochondrial biogenesis and respiration 
through the thermogenic coactivator PGC-1. Cell 98 ,115-124.
12. Puigserver, P., and Spiegelman, B.M. (2003). Peroxisome proliferator-activated 
receptor-gamma coactivator 1 alpha (PCG-la): transciptional coactivator and 
metabolic regulator. Endocrine Review 24, 78-90.
13. Czubryt, M.P., McAnally, J., Fishman, G.I., and Olson, E.N. (2003). Regulation 
of peroxisome proliferator-activated receptor coactivator 1 (PGC-1) and 
mitochondrial function by MEF2 and HDAC5. Proc.Nati.Acad.Sci. 100,1711- 
1716.
14. Suliman, H.B., Welty-Wolf, K.E., Carraway, M.S., Tatro, L., and Piantadosi, C.A. 
(2004). Lipopolysaccharide induces oxidative cardiac mitochondrial damage and 
biogenesis. Cardiovascular Research 64, 279-288.
15. Williams, R.S. (1986). Mitochondrial gene expression in mammalian striated 
muscle. Evidence that variation in gene dosage is the major regulatory event. J. 
Biol. Chem. 261,12390-12394.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
98
16. Wu, H., Kanatous, S.B., Thurmond, F.A., Gallardo, T., Isotani, E., Bassel-Duby, 
R., and et al. (2002). Regulation of mitochondrial gene expression by contractile 
activity in skeletal muscle by CAMK. Science 296, 349-352.
17. Rouse, J., Cohen, P., and Trigon, S. (1994). A novel kinase cascade triggered by 
stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of 
the small heat shock proteins. Cell 78,1027-1037.
18. Han, J., Lee, J.D., Bibbs, L., and Ulevitch, R.J. (1994). A MAP kinase targeted by 
endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811.
19. Freshney, N.W., Rawlinson, L., Guesdon, F., and et al. (1994). Inter leukin -1 
activates a novel protein kinase cascade that results in the phosphorylation of 
Hsp27. Cell 78,1039-1049.
20. Foltz, I.N., Lee, J.C., Young, P.R., and Schradere, J.W. (1997). Hemopoietic 
growth factors with the exception of interleukin-4 activate the p38 mitogen- 
activated protein kinase pathway. J. Biol. Chem. 272, 3296-3301.
21. Suliman, H.B., Carraway, M.S., Welty-Wolf, K.E., Whorton, A.R., and 
Piantadosi, C.A. (2003). Lipopolysaccharide stimulates mitochondrial biogenesis 
via activation of nuclear respiratory factor-1. J. Biol. Chem. 278, 41510-41518.
22. Chan, T.O., Rittenhouse, S.E., and Tsichlis, P.N. (1999). AKT/PKB and other D3 
phosphoinositide-regulated kinases: Kinase activation by phosphoinositide- 
dependent phosphorylation. Annu. Rev. Biochem. 68, 965-1014.
23. Coffer, P.J., and Woodgett, J.R. (1991). Molecular cloning and characterisation of 
a novel putative protein-serine kinase related to cAMP-dependent and protein 
kinase C famillies. European J. of Biochemistry 201, 475-481.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
99
24. Stephens, L., Anderson, K., Stokoe, D., Erdjument-Bromage, H., Painter, G.F., 
Holmes, A.B., and et al. (1998). Protein kinase B kinases that mediate 
phosphatidylinositol 3,4,5-triphosphate-dependent activation of protein kinase B. 
Science 279, 710-714.
25. Andjelkovic, M., Maria, S.M., Cron, P., Parker, P.J., and Hemmings, B.A. (1999). 
Domain swapping used to investigate the mechnanism of protein kinase B 
regulation by 3-phosphoinositide-dependent protein kinase-1 and Ser 473 kinase. 
Mol.Cell Biol. 19, 5061-5072.
26. Scheid, M.P., Huber, M., Damen, J.E., Huges, M., Kang, V., Neilsen, P., and et 
al. (2002). Phosphatidylinositol-(3,4,5) P3 is essential but not sufficient for 
protein kinase B (PKB) activation; Phosphatidylinsitol-(3,4)P2 is required for 
PKB phosphorylation at Ser 473: studies using cells from SH2-containing inositol
5-phosphatase knockout mice. J.Biol.Chem. 277, 9027-9035.
27. Bellacosa, A.T., Chan, N.N., Ahmed, K., Datta, S., Malstorm, D., Stokoe, F., 
McCormick, F., Feng, J., and Tsichlis, P. (1999). AKT activation by growth 
factors is a multiple step process: the role of the PH domain. Oncogene 77, 313- 
325.
28. Alessi, D.R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., 
and et al. (1996). Mechanism of activation of protein kinase B by insulin and IGF- 
l.EMBO J. 15, 6541-6551.
29. Li, M., Wang, X., Meintzer, M.K., Laessig, T., Bimbaum, M.J., and Heidenreich, 
K.A. (2000). Cyclic Amp promotes neuronal survival by phosphorylation of 
glycogen synthase kinase 3 beta. Mol. Cell Biol. 20, 9356-9363.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
100
30. Loberg, R.D., Vesely, E., and Brosius, F. (2002). Enhanced glycogen synthase 
kinase 3 beta activity mediates hypoxia-induced apoptosis of vascular smooth 
muscle cells and is prevented by glucose transport and metabolism. J Biol. Chem. 
277,41667-41673.
31. Pap, M., and Cooper, G.M. (1998). Role of glycogen synthase kinase-3 in the 
phosphatidylinositol 3- kinase/Akt cell survival pathway. J. Biol. Chem. 275, 
19929-19932.
32. Wu, W., Lee, W.I., Wu, Y.Y., Chen, D., Liu, T.J., Sharma, P.M., and Wang, P.H.
(2000). Expression of constitutively active phosphatidylinositol 3 -kinase inhibits 
activation of caspase 3 and apoptosis of cardiac muscle cells. J. Biol. Chem. 275, 
1275-1281.
33. Araki, T., Hayashi, M., Watanabe, N., Kanuka, H., Yoshino, J., Miura, M., and 
Saruta, T. (2002). Down-regulation of MCI-1 by inhibition of the PI3-K/Akt 
pathway is required for cell shrinkage-dependent cell death. Biochem. Biophys. 
Res. Commun. 290,1275-1281.
34. Takano, H., Zou, Y., Hasegawa, H., Akazawa, H., Nagai, T., and Komuro, I. 
(2003). Oxidative stress-induced signal transduction pathways in cardiac 
myocytes: involvement of ROS in heart disease. Antioxid Redox Signal 6, 789- 
794.
35. Shimizu, S., Narita, M., and Tsujujjimoto, Y. (1999). Bcl-2 family proteins 
regulate the release of apoptogenic cytochrome c by the mitochondrial channel 
VDAC. Nature 399, 4833-4837.
36. Hengartner, M.O. (2000). The biochemistry of apoptosis. Nature 407, 770-776.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
101
37. Chernyak, B.V., and Bemardi, P. (1996). The mitochondrial permeability 
transition pore is modulated by oxidative agents through both pyridine nucleotides 
and glutathione at two separate sites. European J. of Biochemistry 238, 623-630.
38. Imai, M., and Nakagawa, Y. (2003). Biological significance of phospholipid 
hydrogen peroxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. 
Free Radio. Biol. Med. 3 4 ,145-169.
39. Harsdorf, R.V., Li, P.F., and Dietz, R. (1999). Signaling pathways in reactive 
oxygen species-induced cardiomyocyte apoptosis. Circulation 99, 2934-2941.
40. Juhaszova, M., Zorov, D.B., Kim, S.H., Pepe, S., Fu, Q., Fishbein, K.W., Ziman, 
B.D., Wang, S., Ytrehus, K., Antos, C.L., Olson, E.N., and Sclott, S. (2004). 
Glyocgen synthase kinase-3B mediates convergence of protection signaling to 
inhibit the mitochondrial permeability transition pore. J.Clin.Invest. 113,1535- 
1549.
41. Forman, H.J., and Fridovich, I. (1973). Superoxide dismutase: a comparison of 
rate constants. Arch. Biochem. Biophys. 158, 396-400.
42. Fridovich, I. (1976). Superoxide dismutae: Structure and mechanism. Adv. Exp. 
Med. Bio. 74, 530-539.
43. Marklund, S.L. (1980). Distribution of CuZn superoxide dismutase and Mn 
superoxide dismutase in human and extracellular fluids. Acta Physiol. Scand. 
S492, 19-23.
44. Marklund, S.L., Holme, E., and Hellner, L. (1982). Superoxide dismutase in 
extracellular fluids. Clin. Chim. Acta. 126, 41-51.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
102
45. Marklund, S.L. (1982). Human copper-containing superoxide dismutase of high 
molecular weight. Proc. Natl. Acad. Sci. USA 79, 7634-7638.
46. Fattman, C.L., Enghild, J.J., Crapo, J.D., Schaefer, L.M., Yalnickova, Z., and 
Oury, T.D. (2000). Purification and characterization of extracellular superoxide 
dismutase in mouse lung. Biochem. Biophys. Res. Commun. 275, 542-548.
47. Oury, T.D., Crapo, J.D., Valnickova, Z., and Enghild, J.J. (1996). Human 
extracellular superoxide dismutase is a tetramer composed of two disulphide- 
linked dimers: a simplified, high-yield purification of extracellular superoxide 
dismutase. Biochem. J. 317, 51-57.
48. Rae, T.D., Schmidt, P.J., Pufahl, R.A., Culotta, V.C., and O'Halloran, T.V.
(1999). Undetectable intracellular free copper: the requirement of a copper 
chaperone for superoxide dismutase. Science 284, 805-808.
49. Jeney, V., Itoh, S., Wendt, M., Gradek, Q., Ushio-Fukai, M., Harrison, D.G., and 
et al. (2005). Role of antioxidant-1 in extracellular superoxide dismutase function 
and expression. Circ. Res. 96, 723-729.
50. Hjalmarsson, K., Marklund, S.L., Engstrom, A., and Edlund, T. (1987). Isolation 
and sequence of complementary DNA encoding human extracellular superoxide 
dismutase. Proc. Natl. Acad. Sci. USA. 84,6340-6344.
51. Petersen, S.V., Oury, T.D., Valnickova, Z., Thogersen, I.B., Hojrup, P., Crapo, 
J.D., and et al. (2003). The dual nature of human extracellular superoxide 
dismutase: one sequence and two structures. Proc. Natl. Acad. Sci. USA 100, 
13875-13880.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
103
52. Adachi, T., Kodera, T., Ohta, H., Hayashi, K., and Hirano, K. (1992). The heparin 
binding site of human extracellular-superoxide dismutase. Arch. Biochem. 
Biophys. 1297, 155-161.
53. Petersen, S.V., Oury, T.D., Ostergaard, L., Valnickova, Z., Wegrzyn, J., 
Thogersen, I.B., and et al. (2004). Extracellular superoxide dismutase (EC-SOD) 
binds to type 1 collagen and protects against oxidative fragmentation. J. Biol. 
Chem. 279,13705-13710.
54. Karlsson, K., and Marklund, S.L. (1987). Heparin-induced release of extracellular 
superoxide dismutase to human blood plasma. Biochem. J. 242, 55-59.
55. Ookawara, T., Eguchi, H., Nishimura, M., Kizaki, T., Eiji, T., Saitoh, D., and et 
al. (2003). Effects of oxidative stress on the nuclear translocation of extracellular 
superoxide dismutase. Biochem. Biophys. Res. Commun. 303, 914-919.
56. Ookawara, T., Kizaki, T., Takayama, E., Imazeki, N., Matsubara, O., and et al.
(2002). Nuclear translocation of extracellular superoxide dismutase. Biochem. 
Biophys. Res. commun. 296, 54-61.
57. Sandstrom, J., Nilsson, P., Karlsson, K., and Marklund, S.L. (1994). 10-fold 
increase in human plasma extracellular superoxide dismutase content caused by a 
mutation in heparin-binding domain. J. Biol. Chem. 269, 19163-19166.
58. Juul, K., Tybjaerg-Hansen, A., Marklund, S., Heegaard, N.H., Steffensen, R., and 
Sillesen, H. (2004). Genetically reduced antioxidative protection and increased 
ischemic heart disease risk:The Copenhagen City Heart Study. Circulation 109, 
59-65.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
104
59. Fattman, C.L., Schaefer, L.M., and Oury, T.D. (2003). Extracellular superoxide 
dismutase in biology and medicine. Free Radic. Biol. Med. 35,236-256.
60. Carlsson, L.M., Jonsson, J., Edlund, T., and Marklund, S.L. (1995). Mice lacking 
extracellular superoxide dismutase are more sensitive to hyperoxia. Proc. Natl. 
Acad. Sci. USA. 92, 6264-6268.
61. Mamo, L.B., Suliman, H.B., Giles, B.L., Auten, R.L., Piantadosi, C.A., and 
Nozik-Grayck, E. (2004). Discordant extracellular superoxide dismutase 
expression and activity in neonatal hyperoxic lung. Am. J. Respir. Crit. Care Med. 
770,313-318.
62. Stralin, P., and Marklund, S.L. (2001). Vasoactive factors and growth factors alter 
vascular smooth muscle cell EC-SOD expression. Am. J. Physiol. Heart Circ. 
Physiol. 281, H1621-1629.
63. Fukai, T., Siegfried, M.R., Ushio-Fukai, M., Cheng, Y., Kojda, G., and Harrison,
D.G. (2000). Regulation of the vascular extracellular superoxide dismutase by 
nitric oxide and exercise training. J. Clin. Invest. 105, 1631-1639.
64. Adachi, T., Ohta, H., Hayashi, K., Hirano, K., and Marklund, S.L. (1992). The 
site of nonenzymic glycation of human extracellular-superoxide dismutase in 
vitro. Free Radic. Biol. Med. 13, 205-210.
65. Adachi, T., Inoue, M., Hara, H., and Suzuki, S. (2004). Effects of PPAR gamma 
ligands and C/EBPbeta enhancer on expression of extracellular-superoxide 
dismutase. Redox Rep. 9, 207-212.
66. Faraci, F.M., and Didion, S.P. (2004). Vascular protection: superoxide dismutase 
isoforms in the vessel wall. Arterioscler. Thromb. Vase. Biol. 24 ,1367-1373.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
105
67. Demchenko, I.T., Oury, T.D., Crapo, J.D., and Piantadosi, C.A. (2002).
Regulation of the brain's vascular responses to oxygen. Circ. Res. 91, 1031-1037.
68. Anderson, T.J., Meredith, I.T., Yeung, A.C., Frei, B., Selwyn, A.P., and Ganz, P. 
(1995). The effect of cholesterol-lowering and antioxidant therapy on 
endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332,488-493.
69. Ahmed, M.N., Suliman, H.B., Folz, R.J., and Nozik-Grayck, E. (2003). 
Extracellular superoxide dismutase protects lung development in hyperoxia- 
exposed newborn mice. Am. J. Respir. Crit. Care Med. 167,400-405.
70. Folz, R.J., Abushamaa, A.M., and Suliman, H.B. (1999). Extracellular superoxide 
dismutase in the airways of transgenic mice reduces inflammation and attenuates 
lung toxicity following hyperoxia. J. Clin. Invest. 103, 1055-1066.
71. Oury, T.D., Ho, Y., Piantadosi, C.A., and Crapo, J.D. (1992). Extracellular 
superoxide dismutase, nitric oxide and central nervous system 02 toxicity. Proc. 
Natl. Acad. Sci. USA. 89, 9715-9719.
72. Suliman, H.B., Carraway, M.S., Velsor, L.W., Day, B.J., Giho, A.J., and 
Piantadosi, C.A. (2002). Rapid mtDNA deletion by oxidants in rat liver 
mitochondria after hemin exposure. Free Radic.Biol.Med. 32, 246-256.
73. Crapo, J.D., Me Cord, J.M., and Fridovich, I. (1978). Preparation and assay of 
superoxide dismutases. Methods Enzymol 53, 382-393.
74. Marklund, S.L. (1990). Analysis of extracellular superoxide dismutase in tissue 
homogenates and extracellular fluids. Methods Enzymol 186, 260-265.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
106
75. Puigserver, P., Rhee, J., Wu, Z., Yoon, J.C., Zhang, C.Y., and et al. (2001). 
Cytokine stimulation of energy expenditure through p38 MAP kinase activation 
of PPAR gamma coactivator-1. Molecular Cell 8, 971-982.
76. Suliman, H.B., Ali, M.E., and Piantadosi, C.A. (2004). Superoxide dismutase-3 
promotes full expression of the EPO response to hypoxia. Blood 104,43-50.
77. Retel, J., Hoebee, B., Braun, J.E., Lutgerink, J.T., and et al. (1993). Mutational 
specificity of oxidative DNA damage. Mutat. Res. 299, 165-182.
78. Halliwell, B., and Aruoma, O.I. (1991). DNA damage by oxygen-derived species: 
its mechanism and measurements in mammalian systems. FASEB Lett. 281, 9-19.
79. Dianzani, M.U. (1993). Lipid peroxidation and cancer. Crit. Rev. Oncol. Hematol. 
15 ,125-147.
80. Jahngir, A., Ozcan, E.L., and Holmuhamedov, T.A. (2001). Increased calcium 
vulnerability of senescent cardiac mitochondria: a protective role for a 
mitochondrial potassium channel opener. Mech. Ageing Dev. 122,1073-1086.
81. Falkenberg, M., Gaspari, M., Rantanen, A., Trifunovic, A., Larsson, N.G., and 
Gustafsson, C.M. (2002). Mitochondrial transcription factors B1 and B2 activate 
transcription of human mtDNA. Nat. Genet. 3 ,289-294.
82. Gordon, J.W., Rungi, A.A., Inagaki, H., and Hood, D.A. (2001). Effects of 
contractile activity on mitochondrial transcription factor A expression in skeletal 
muscle. J. Appl. Physiol. 90, 389-396.
83. Scarpulla, R.C. (2002). Transcriptional activators and co-activators in the nuclear 
control of mitochondrial function in mammalian cells. Gene 286, 81-89.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
107
84. Villena, J.A., Martin, I., Vinas, O., Cormand, B., Iglesias, R., Mampel, T., Giralt, 
M., and Villarroya, F. (1994). ETS transcription factors regulate the expression of 
the gene for the human mitochondrial ATP synthase beta-subunit. J.Biol.Chem. 
269, 32649-32174.
85. Nelson, B.D., Luciakova, K., Li, R., and Betina, S. (1995). The role of thyroid 
hormone and promoter diversity in the regulation of nuclear encoded 
mitochondrial proteins. Biochem. Biophys. Acta. 1271, 85-91.
86. Bedogni, B., Pani, G., Colavitti, R., Riccio, A., Borrello, S., Murphy, M., Smith, 
R., Eboli, M.L., and Galeotti, T. (2003). Redox regulation of cAMP-responive 
element-binding protein and induction of manganese superoxide dismutase in 
nerve growth factor cell survival. J. Biol. Chem. 278,16510-16519.
87. Chakraborti, S., and Chakraborti, T. (1998). Oxidant-mediated activation of 
mitogen-activated protein kinases and nuclear transcription factors in the 
cardiovascular system: a breif overview. Cell Signal 10, 675-683.
88. Matsui, T., Li, L., Del Monte, F., Fukui, Y., Franke, T.F., Hajjar, R.J., and et al. 
(1999). Adenoviral gene transfer of activated phosphatidylinositol 3-kinase and 
Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100,2373- 
2379.
89. Matsui, T., Tao, J., Del Monte, F., Lee, K.H., Li, L., Picard, M., and et al. (2001). 
Akt activation preserves cardiac function and prevents injury after transient 
cardiac ischemia in vivo. Circulation 104, 330-335.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
90. Gao, N., Ding, M., Zheng, J.Z., Leonard, S.S., Liu, K.J., Shi, X., and Jiang, B.H.
(2002). Vanadate-induced expression of hypoxia -inducible factor 1 alpha and 
vascular endothelial growth factor through phosphatidylinositol 3 kinase/Akt 
pathway and reactive oxygen species. J. Biol. Chem. 277, 31968-31971.
91. Kim, Y.K., Kim, S.J., Yatan, A., Haung, Y., Castelli, G., Vatner, D.E., and et al.
(2003). Mechanism of enhanced cardiac function in mice with hypertrophy 
induced by overexpressed Akt. J. Biol. Chem. 278, 47622-47628.
92. Negoro, S., Oh, H.T., One, E., Kunisada, K., Fujio, Y., Walsh, K., and et al.
(2001). Glycogen 130 regulates cardiac myocytes survival in doxorubicin-induced 
apoptosis through phosphatidylinsitol 3-kinase/Akt phosphorylation and Bcl- 
xL/caspase-3 interaction. Circulation 103, 555-561.
93. Fujita, E., Jinbo, A., Matuzaki, H., Konishi, H., Kikkawa, U., and Momoi, T. 
(1999). Akt phosphorylation site found in human caspase-9 is absent in mouse 
caspase-9. Biochem. Biophys. Res. Commun. 264, 550-555.
94. Burnet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, L.S., Anderson, M.J., 
Arden, K.C., Blenis, J., and Greenberg, M.E. (1999). AKT promotes cell survival 
by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857- 
868 .
95. Somervaille, T.C., Linch, D.C., and Khwaja, A. (2001). Growth factor withdrawal 
from primary human erythroid progenitors induces apoptosis through a pathway 
involving glycogen synthase kinase 3 and Bax. Blood 9 8 ,1374-1381.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
96. Hang, Y., Lee, C., and Julie, C. (2004). Adrenomedullin protects against 
myocardial apoptosis after ischemia/reperfiision through activation of Akt-GSK 
signaling. Hypertension 43 ,109-116.
97. Tong, H., Imahashi, K., Steenbergen, C., and Murphy, E. (2002). Phosphorylation 
of glycogen synthase kinase-3- kinase—dependent pathway is cardioprotective. 
Circ. Res. 90, 377-379.
98. Gross, E.R., Hsu, A.K., and Gross, G.J. (2004). Opioid-induced cardioprotection 
occurs via glycogen synthase kinase beta inhibition during reperfusion in intact 
rat hearts. Circ. Res. 94, 960-966.
99. Matsui, T., Li, L., Wu, J.C., Cook, S.A., Nagoshi, T., Picard, M.H., and et al.
(2002). Phenotypic spectrum caused by transgenic overexpression of activated 
Akt in the heart. J. Biol. Chem. 277, 22896-22901.
100. Shioi, T., Mcmullen, J.R., Kang, P.M., Douglas, P.S., Obata, T., Franke, T.F., and 
et al. (2002). Akt/protein kinase B promotes organ growth in transgenic mice. 
Mol. Cell Biol. 22, 2799-2809.
101. Haas-Kogan, D., Shalev, N., Wong, M., Mills, G., Yount, G., and Stokoe, D. 
(1998). Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due 
to supperssor PTEN/MMAC. Curr. Biol. 8 ,1195-1198.
102. Myers, M.P., Pass, I., Batty, I.H., Van der Kaay, J., Stolarow, J.P., Hemmings, 
B.A., and et al. (1998). The lipid phosphatase activity of PTEN is critical for its 
tumor suppressor function. Proc. Natl. Acad. Sci. USA 95, 13513-13518.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
110
103. Maehama, T., and Dixon, J.E. (1998). The tumor suppressor PTEN/MMAC1, 
dephosphorylates the lipid second messenger, phophatidylinositol 3,4,5- 
triphosphate. J. Biol. Chem. 273,13375-13378.
104. Resjo, S., Gorannnnsson, O., Hamdajl, L., Zolnierowicz, S., Manganiello, V., and 
Degerman, E. (2002). Protein phosphatase A2 is the main phosphatase involved in 
the regulation of protein kinase B in rat adipocytes. Cell Signal 14, 231-238.
105. Cardone, M.H., Salvesen, G.S., Widmann, C., Johnson, G., and Frisch, S.M. 
(1997). The regulation of anoikis: MEkk-1 activation requires cleavage by 
caspases. Cell 90, 315-323.
106. Zielger-Heitbrock, H.W., Blumenstein, M., Kafferlein, E., and et al. (1992). In 
vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, 
interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology 
75, 264-268.
107. Levitsky, S., Laurikka, J., Stewart, R.D., Campos, C.T., Lahey, S.J., and Mccully, 
J.D. (2003). Mitochondrial DNA deletions in coronary artery bypass grafting 
patients. Eur. J. Cardiothorac. Surg. 24, 777-784.
108. Botto, N., Berti, S., Manfredi, S., Al-jabri, A., Federici, C., Clerico, A., Ciofini,
E., Biagini, A., and Andreassi, M.G. (2005). Detection of mtDNA with 4977 bp 
deletion in blood cells and atherosclerotic lesions of patients with coronary artery 
disease. Mutat. Res. 570, 81-88.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
109. Hodge, D.R., Peng, B., Pompeia, C., Thomas, S., Cho, E., Clausen, P.A., 
Marquez, V.E., and Farrar, W.L. (2005). Epigenetic silence of manganese 
superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells 
increases cell proliferation. Cancer Biol. Ther. 4, 585-592.
110. Haung, Y., Tongrong, H.E., and Domann, F.E. (1999). Decreased expression of 
manganese superoxide dismutase in transformed cells is associated with increased 
cytosine methylation of the SOD2 gene. DNA and Cell Biology 18, 643-652.
111. Scarpulla, R.C. (2002). Nuclear activators and co-activators in mammalian 
mitochondrial biogenesis. Biochem. Biophys. acta. 1578,1-14.
112. Choi, Y.S., Kim, S., Kyu, L.H., Lee, K.U., and Pak, Y.K. (2004). In vitro 
methylation of nuclear respiratory factor-1 binding site suppresses the promoter 
activity of mitochondrial transcription factor A. Biochem. Biophys. Res.
Commun. 314, 118-128.
113. Freyssnet, D., Di Carlo, M., and Hood, D.A. (1999). Calcium-dependent 
regulation of cytochrome c gene expression in skeletal muscle cells. Identification 
of a protein kinase c-dependent pathway. J. Biol. Chem. 274,9305-9311.
114. Zong, H., Ren, J.M., Young, L.H., Pypaert, M., Mu, J., Bimbaum, M.J., and 
Shulman, G.I. (2002). AMP kinase is requried for mitochondrial biogenesis in 
skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. 
USA 9 9 ,15983-15987.
115. Steenbergen, C. (2002). The role of p38 mitogen-activated protein kinase in 
myocardial ischemia /reperfusion injury; relation to ischemic preconditioning. 
Basic Res. Cardiol. 97, 276-285.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
116. Rakhit, R.D., Kabir, A.N., Mockridge, J.W., Saurin, A., and Marber, M.S. (2001). 
Role of G proteins and modulation of p38 MAPK activation in the protection by 
nitric oxide against ischemia-reoxygenation injury. Biochem. Biophys. Res. 
Commun. 286, 995-1002.
117. Barger, P.M., Browning, A.C., Gamer, A.N., and Kelly, D.P. (2001). p38 
mitogen-activated protein kinase activates peroxisome proliferator-activated 
receptor alpha. J. Biol. Chem. 276, 44495-44501.
118. Homig, B., Landmesser, U., Kohler, C., Ahlersmann, D., Spiekermann, S., 
Christoph, A., Tatge, H., and Drexler, H. (2001). Comparative effect of ACE 
inhibition and angiotensin II type 1 receptor anatgonism on bioavailability of 
nitric oxide in patients with coronary artery disease: role of superoxide dismutase. 
Circulation 103,799-805.
119. Landmesser, U., Merten, R., Spiekermann, S., Buttner, K., Drexler, H., and 
Homig, B. (2000). Vascular extracellular superoxide dismutase: relation to 
endothelium dependent vasodilatation. Circulation 101, 2264-2270.
120. Wang, X.L., Adachi, T., Sim, A.S., and Wilcken, D.E. (1998). Plasma 
extracellular superoxide dismutase levels in an Australian population with 
coronary artery disease. Arterioscler. Thromb. Vase. Biol. 18, 1915-1921.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
121.
122.
Agrawal, R.S., Muangman, S., Layne, M.D., Melo, L., Perrella, M.A., Lee, R.T., 
Zhang, L., Ilasaca, M., Lopez, I., and Dzau, V.J. (2004). Pre-emptive gene 
therapy using recombinant adeno-associated virus delivery of extracellular 
superoxide dismutase protects heart against ischemic reperfusion injury, improves 
ventricular function and prolongs survival. Gene Therapy 11, 962-969.
Li, Q., Bolli, R., Qiu, Y., Tang, X., Guo, Y., and French, B. (2001). Gene therapy 
with extracellular superoxide dismutase protects conscious rabbits against 
myocardial infarction. Circulation 103, 1893-1898.





1996-2006 Ph.D. in Biochemistry and Molecular Biology at Eastern Virginia Medical 
School/Old Dominion University, Norfolk, VA 
1993-1995 Master Degree in Biochemistry, Suez Canal University, Ismailia, Egypt
1981-1987 MD Degree from the Medical School, Suez Canal University, Ismailia,
Egypt
Professional Experience
1993-1996 Assistant Lecturer in the Biochemistry Department, Medical School, Suez 
Canal University, Ismailia, Egypt.
1989-1993 Researcher in the Biochemistry Department, Suez Canal University, 
Ismailia, Egypt
1989-1990 Family doctor in an Egyptian governmental health care unit.
1988-1989 Intern in the Suez Canal Hospital, Ismailia, Egypt
Thesis
Master Thesis: “Level of Apo A lipoprotein among hypertensive and Diabetic patients” 
1993, Department of Biochemistry, Medical School, Suez Canal University, Ismailia, 
Egypt.
Ph.D Thesis: Research part was accomplished at Duke Medical Center, Department of 
Anesthesiology and Medicine, Center for Hyperbaric Medicine and environmental 
Physiology: “Extracellular Superoxide Dismutase protects Cardiomyocytes during 
Hy peroxia”2005.
Publications:
1- PETER J. MOLER, JEAN Schott, Anthony O. Gramolini, Keith W. Dllly, Silvia 
Guatimosim, William H. dubell, Long—sheng Song, Karine Haurogene, Florence Kyndt, 
Mervat E. Ali, Terry B. Rogers, W.J. lederer, denis Escands, herve le marec, and Vann 
Bennett. Ankyrin-B mutation causes type 4 long Qt cardiac arrhythmia and sudden 
cardiac death. Nature vol. 421 6 Februray 2003.
2- Hagir B. Suliman, Mervat E. Ali, and Claude A. Piantadosi, “Superoxide dismutase- 
3 promotes full expression of the EPO response to hypoxia”. Blood, 1 July 2004, Vol. 
104, No. l,pp. 43-50.
3- Mervat E. Ali, Hajer B. Suliman, and Claude A. Piantadosi, “Superoxide dismutase- 
3 protects cardiomyocytes after exposure to hyperoxia”. In preparation.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
